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Chapter 1 
 
Introduction: Pathophysiology of liver 
sinusoidal endothelial cells and their 
fenestrations 
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1. Pathophysiology of liver sinusoidal endothelial cells and 
their fenestrations 
 
1.1. Introduction 
 
Owing to its strategic position in the liver sinusoid, pathologic and morphologic 
alterations of the Liver Sinusoidal Endothelial Cell (LSEC) have far-reaching 
repercussions for the whole liver and systemic metabolism. LSECs are perforated 
with fenestrations, which are pores that facilitate the transfer of lipoproteins and 
macromolecules between blood and hepatocytes. Loss of LSEC porosity is termed 
defenestration, which can result from loss of fenestrations and/ or decreases in 
fenestration diameter. Gram negative bacterial endotoxin (Lipopolysaccharide, LPS) 
has marked effects on LSEC morphology, including induction LSEC defenestration.  
Sepsis is associated with hyperlipidemia, and proposed mechanisms include inhibition 
of tissue lipoprotein lipase and increased triglyceride production by the liver. The 
LSEC has an increasingly recognized role in hyperlipidemia. Conditions associated 
with reduced numbers of fenestrations such as ageing and bacterial infections are 
associated with impaired lipoprotein and chylomicron remnant uptake by the liver and 
consequent hyperlipidemia. Given the role of the LSEC in liver allograft rejection and 
hyperlipidemia, changes in the LSEC induced by LPS may have significant clinical 
implications.  
 
This literature review summarizes the key concept of the liver sieve including the 
morphology and dynamics of LSEC fenestrations and its significance in 
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pathophysiology. This review also includes details of the immune function of the liver 
with a focus on the LSEC and its response to gram negative bacterial toxins, 
especially LPS. Another gram negative bacterium Pseudomonas aeruginosa, its toxin 
pyocyanin, and its relevance to liver infections have also been discussed. This review 
also encompasses age-related liver sinusoidal changes, which include LSEC 
defenestration, and may impede the transfer of small-lipoproteins and oxygen across 
the sinusoidal endothelium.  
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1.2. The liver acinus and liver sinusoidal cells 
 
In humans, the liver is functionally divided into right (including caudate and quadrate 
lobes) and left lobes and further subdivided into 8 segments by divisions of the right, 
middle and left hepatic veins, each segment receiving its own portal pedicle (Fig. 1.1). 
 
Figure 1.1. Segmental anatomy of the liver showing the eight hepatic segments 
II-IV the left hemiliver; V-VIII the right hemiliver (Kumar and Clark, 2005). 
 
 
 
The liver is supplied by the hepatic artery (25% of the total blood flow and 50% of 
oxygen delivery) and the portal vein (75% of the total blood flow and 50% of oxygen) 
(Kumar and Clark, 2005). 
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The acinus is the functional unit of the liver (Fig. 1.2). Each acinus consists of 
parenchyma composed of hepatocytes supplied by the smallest portal tracts containing 
portal vein radicles, hepatic arterioles and bile ductules. Hepatocytes make up 
approximately 60% of all hepatic cells and 80% of total hepatic volume. The portal 
tract for each acinus is called the portal triad. The hepatic sinusoids which carry blood 
from the hepatic portal vein and the hepatic artery emanate from the portal triad and 
radiate outwards. The hepatocytes are drained by the central veins, also addressed as 
the terminal hepatic veins. The hepatocytes in the surrounding the portal triads 
(periportal area, zone 1) are well supplied with oxygenated blood and are generally 
more resistant to hypoxia and ischaemic injury than the hepatocytes surrounding the 
central veins (pericentral area, zone 3).  
Four types of cells constitute the hepatic sinusoid, namely Liver Sinusoidal 
Endothelial Cells (LSECs), Kupffer cells (KCs), stellate cells (SCs), and pit cells, 
each with specific morphology and function. LSECs make up approximately 20% of 
the hepatic cells, KCs 15%, and SCs 5%. Depending on the disease process, each cell 
type can undergo morphologic or quantitative changes (Fraser et al, 1986; Wisse et al, 
1996).   
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Figure 1.2. Diagram of an acinus 
Zones 1, 2 and 3 are defined according to their relationship to the portal triads and 
central veins.   Zone 1, which is periportal, is best oxygenated. Zone 3 is supplied by 
blood remote from afferent vessels and is in the microcirculatory periphery of the 
acinus. The pericentral area (star shaped green area around THV) is formed by the 
most peripheral parts of zone 3 of several adjacent acini and is the least well 
oxygenated. THV, Terminal Hepatic Venule or Central Vein; PT, Portal Triad 
(Kumar and Clark, 2005). 
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LSECs constitute the liver sinusoidal capillary wall. They lack basement membrane 
and possess pores termed fenestrations (Bouwens et al, 1992; Wisse et al, 1996). KCs 
phagocytose and degrade gastrointestinal antigens, bacteria and toxins which are 
carried by the portal vein to the liver (Bouwens, 1988; Wake et al, 1989). They also 
assist in tissue repair, clearance of senescent and damaged erythrocytes, T and B 
lymphocyte interactions and in antigen presentation (Kmiec, 2001). Stellate cells (Ito 
cells) store retinoids (Kmiec, 2001; Rockey, 1997) in their resting state and contain 
the intermediate filament, desmin. During hepatic injury, they undergo a radical 
transformation into a myofibroblast type cell that produces copious quantities of 
collagen types I, III and IV (Rockey, 1997). Pit cells are situated in liver sinusoidal 
walls, in portal tracts and in granuloma-like cellular aggregates (Bouwens et al, 1990). 
It is speculated that they are hepatic large granular lymphocytes or natural killer cells 
(Bouwens, 1988; Luo et al, 2000). 
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1.3. LSECs contribute to the liver sieve apparatus 
 
LSECs constitute the lining or wall of the hepatic sinusoid. They lack basement 
membrane (Bouwens et al, 1992; Wisse et al, 1996) and possess fenestrations with 
diameters ranging from 100 to 200 nm (Wisse et al, 1996; Wisse et al, 1985). LSEC 
fenestrations are visible on electron microscopy as circular or oval perforations 
arranged in sieve plates within the thin extensions of the cytoplasm (Henriksen et al, 
1984).  Both fenestrations and sieve plates are structurally delineated by cytoskeleton 
elements (Braet(b) et al, 1995). The subendothelial space that lies between the 
sinusoids and hepatocytes is called the space of Disse, which contains a low-density 
matrix of basement membrane constituents and stellate cells.  The LSECs, which 
contain fenestrations arranged in sieve plates, and the subendothelial space of Disse, 
containing extracellular matrix, together constitute the liver sieve. Since LSECs have 
fenestrations and lack basement membrane, molecules from the sinusoidal lumen can 
translocate directly through the fenestrations, to the low-density matrix of the space of 
Disse, to make contact with hepatocyte microvilli, and vice versa (Fraser et al, 1995; 
Wisse et al, 1996). Blood constituents that are too large to pass through fenestrations, 
such as erythrocytes and chylomicrons are excluded from the space of Disse, while 
smaller molecules, such as Chylomicron Remnants (CHR) are able to pass directly 
through the fenestrations (Wisse, 1970). 
 
LSEC porosity is determined by fenestration frequency (F/um2) and fenestration 
diameter (FD). The total area covered by the fenestrations has been estimated to 
account for approximately 10% of the LSEC surface area (Wisse, 1970). The natural 
porosity of the hepatic sinusoids increases from the portal triad (zone 1) towards the 
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central vein (zone 3) owing to a slight increase in fenestration frequency (Horn et al, 
1986; Wisse et al, 1983) and perhaps also an increase in fenestration diameter (Vidal-
Vanaclocha and Barbera-Guillem, 1985; Wisse et al, 1983). Vidal-Vanaclocha and 
co-workers observed approximately double the number of sieve plates and the number 
of fenestrations per sieve plate in the pericentral sinusoids than in the periportal 
sinusoids (Vidal-Vanaclocha and Barbera-Guillem, 1985). They classified 
fenestrations into two types, clustered pores, which are more prevalent in the 
pericentral sinusoids, and free pores, which are more prevalent in the periportal 
sinusoids (Vidal-Vanaclocha and Barbera-Guillem, 1985). 
 
Utilizing “endothelial massage”, erythrocytes and leukocytes may flush plasma 
through the fenestrations in the endothelium (Wisse et al, 1985). Permeation 
selectivity of different molecules is regulated by the fenestration sizes, the molecule 
sizes, and the transport kinetics of the molecules relative to steric and frictional 
properties of the fenestrations. Therefore, passage of small sized particles like 
albumin (7 nm diameter), is probably not size-limited in the normal liver. However, 
passage of larger molecules like IgM antibodies (10- 20 nm diameter) may be size-
limited.  
 
Fenestration diameters and frequency patterns vary from species to species. Utilizing 
fenestration diameter and fenestration frequency as parameters, these patterns have 
been reviewed (Table. 1.1), adapted from(Cogger and Le Couteur, 2008). 
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Table 1.1. Inter-species variations in fenestration parameters 
Adapted from (Cogger and Le Couteur, 2008) 
 
 
 
Fenestrations have been reported in all of the very wide range of species studied. 
Some of the many reports in different species are presented in Table.1.1, showing that 
fenestrations are widespread, and quite similar in size and distribution, in animals and 
humans. Porosity is the % of the surface area of the sinusoid covered with 
fenestrations. The frequency of fenestration refers to the number of fenestrations per 
unit area. 
 
Alterations in fenestration diameter or fenestration frequency can affect exchange of 
plasma across the sinusoidal lumen and the space of Disse, influencing liver function 
Species Porosity 
(area %) 
Diameter 
(nm) 
Frequency 
(per µm2) 
Citation 
Rat (zone 1) 6.0±0.2 111±1 9.1±0.3 (Wisse et al, 1983) 
Rat (zone 3) 7.9±0.3 105±0.2 13.3±0.5 (Wisse et al, 1983) 
Rat 4.1±2.3 73±1 2.7±1.1 (Le Couteur et al, 2001) 
Rat 12.0±2.1 110±7 12.4±3.6 (Fraser et al, 1986) 
Mice 4.1±2.2 74±4  (Warren et al, 2005) 
Rabbit 5.2±0.9 60±5 17.3±3.8 (Fraser et al, 1986) 
Rabbit 4.0±1.5 69±8 12.7±2.5 (Fraser et al, 1986) 
Chicken 3.6±1.6 99±15 3.9±0.9 (Fraser et al, 1986) 
Chicken 2.2±0.6 90±18 2.9±0.3 (Fraser et al, 1986) 
Rainbow trout  123  (McCuskey et al, 1986) 
Gold Fish  50-200  (Nopanitaya et al, 1979) 
Dog 6.7 118±2 7.2 (McCuskey et al, 1986) 
Sheep  60±2  (Wright et al, 1983) 
Baboon 2.6±0.2 50±1 12.1±0.8 (Jamieson et al, 2007) 
Baboon 4.2±0.5 58±1 9.4±0.9 (Cogger et al, 2003) 
Baboon 1.8 82 3.3 (Mak and Lieber, 1984) 
Human (zone 1) 7.6  19 (Horn et al, 1986) 
Human (zone 3) 9.1  23.5 (Horn et al, 1986) 
Human (zone 1) 3.4±0.2 170±12 9.8±1.8 (Madarame et al, 1991) 
Human (zone 3) 4.0±0.4 160±10 11.2±2.6 (Madarame et al, 1991) 
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(Henriksen et al, 1984). Loss of LSEC porosity is termed defenestration and can be 
due to reduction in fenestration frequency and/ or fenestration diameter. In specific 
pathological processes, defenestration occurs along with endothelial thickening and 
deposition of excessive extracellular matrix in the subendothelial space of Disse. 
These changes, called capillarization in cirrhosis and pseudocapillarization in ageing, 
pose an impediment to the transfer of many substrates from the sinusoidal lumen to 
the hepatocytes, through the space of Disse. 
 
Figure 1.3. Transmission electron micrograph of the liver from a young adult rat 
Transmission electron micrograph of the perfused liver (Magnification 17000×) of a 
young adult rat aged 6 months showing the liver sieve apparatus (Le Couteur et al, 
2002); (*, Fenestration; S, Sinusoidal Space; E, Endothelium; D, Space of Disse; H, 
Hepatocyte). 
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1.4. LSEC fenestration morphology and the role of the cytoskeleton in 
fenestration formation and regulation 
 
LSEC fenestrations (* in Fig 1.3) are inducible structures and the cytoskeleton is 
involved in their formation (Braet(a) et al, 1995; Steffan et al, 1987). Each 
fenestration is circumscribed by a filamentous, Fenestration Associated Cytoskeleton 
Ring (FACR). The average filament thickness of the FACR averages around 16 nm 
(Braet(b) et al, 1995). The sieve plates, which enclose fenestrations, are encircled by 
microtubules. The sieve plates and the fenestrations are linked to the cell cytoskeletal 
tree. Agents that alter the sieve plate structure and porosity induce cytoskeletal 
changes and vice versa (Braet(a) et al, 1995). Routinely used actin-disruptor agents 
like cytochalasin B and other actin-disruptor agents including marine-sponge-derived 
macrolides like latrunculin A, jasplakinolides (jaspamides), swinholide A, 
misakinolide A, each with its distinct specific actin-disrupting property, have also 
been used to study LSEC cytoskeletal changes and fenestration dynamics (Braet et al, 
1996; Braet et al, 2003; Braet et al, 1998; Braet et al, 2002; Braet(a) et al, 1995; 
Spector et al, 1999). The findings of these studies are summarized in Table. 1.2. 
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Table 1.2. Use of actin-disrupting agents to elucidate LSEC fenestration 
dynamics 
 
 Treatment Agent 
 
Por 
 
Fen 
Diameter 
Fen 
Freq 
Cytoskeletal 
Changes 
Other 
Changes 
Citations 
 
1 Antimycin A ↓↓↓ ↓↓↓ ↑ Actin disassembly 
↓ATP + 
Sieve plate 
protrusion 
(Braet et al, 
2003)
 
2 Cytochalasin B ↑↑↑ None, Variable ↑↑ 
Actin 
disassembly + 
↑Polymerization 
FFCs not 
connected to 
fenestrations 
(Braet et al, 
1996; Braet(a) 
et al, 1995; 
Spector et al, 
1999; Steffan 
et al, 1987)
 
3 Latrunculin A  ↓ ↑↑ 
Actin 
disassembly + 
↑Polymerization 
FFCs not 
connected to 
fenestrations 
(Braet et al, 
1996; Spector 
et al, 1999)
 
4 Misakinolide A  ↓ ↑↑ 
Actin 
disassembly + 
↑Polymerization 
FFCs 
connected to 
fenestrations 
(Braet et al, 
1998; Spector 
et al, 1999)
 
5 Swinholide A  ↓ ↑↑ 
Actin 
disassembly + 
↑Polymerization 
FFCs not 
connected to 
fenestrations 
(Braet et al, 
1998; Spector 
et al, 1999)
 
6 Jasplakinolide  ↓ ↑ 
Actin 
disassembly + 
F- actin bundle 
loss + 
↑ F- actin dots 
FFCs not 
connected to 
fenestrations 
(Braet et al, 
1998; Spector 
et al, 1999)
 
7 Hydrohalichondramide  ↓ ↑↑ 
Actin 
disassembly + 
↑Polymerization 
FFCs not 
connected to 
fenestrations 
(Braet et al, 
2002; Spector 
et al, 1999)
 
8 Dihydrohalichondramide  ↓ ↑↑ 
Actin 
disassembly + 
↑Polymerization 
FFCs 
connected to 
fenestrations 
(Braet et al, 
2002; Spector 
et al, 1999)
 
 
Por- Porosity; Fen Diameter- Fenestration Diameter; Fen Freq- Fenestration 
Frequency; FFC- Fenestration Forming Center. 
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1.5. Effect of endobiotics, xenobiotics and patho-physiologic processes on LSEC 
fenestration 
 
Some endogenous and exogenous agents and pathophysiologic conditions that alter 
LSEC fenestrations are summarized in Table 1.3. 
 
1.5.1. Autonomic regulation and cellular mediators  
 
Hormones of the autonomic nervous system have effects on LSEC fenestration 
dimensions. Acetylcholine dilates LSEC fenestrations, while noradrenaline constricts 
them (Tsukada et al, 1986; Wisse et al, 1980). Serotonin (5 HT) increases intracellular 
calcium, leading to myosin light chain phosphorylation and constriction of 
fenestrations (Braet(a) et al, 1995; Gatmaitan et al, 1996). This indicates that 
fenestration contraction is active process mediated via LSEC Ca2+.  
 
Ca2+ and adenosine triphosphate (ATP) have been shown to constrict fenestrations, 
thereby reducing porosity (Braet et al, 2003; Gatmaitan et al, 1996; Oda et al, 1993). 
Additionally, the Ca2+-calmodulin-actomyosin system has been implicated in the 
structural regulation of LSEC fenestrations (Oda et al, 1993).   
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1.5.2. Alcohol or nicotine exposure  
 
Acute and medium-term exposure to alcohol in rats in vivo or in isolated LSECs in 
vitro is associated with increased LSEC fenestration diameter, frequency and porosity 
(Braet(a) et al, 1995; Charels et al, 1986; Fraser et al, 1980; Mori et al, 1991; Sarphie 
et al, 1997). In contrast, with chronic long-term alcohol intake, humans (Horn et al, 
1987) and mice (Sarphie et al, 1997) display LSEC defenestration. It has therefore 
been speculated that increased transmission of larger chylomicrons across the LSECs 
with acute and medium term alcohol consumption may be a crucial step in the 
pathogenesis of alcoholic hepatic steatosis (Fraser et al, 1980). Alcoholic liver disease 
can have three overlapping sequential phases, namely alcoholic hepatic steatosis, 
alcoholic hepatitis, and alcoholic cirrhosis. It is possible that following short-
term/medium-term alcohol consumption after the alcoholic steatosis/hepatitis phase 
where the LSEC porosity is increased, and prior to the cirrhotic phase of alcoholic 
liver disease where the LSEC porosity is decreased, LSEC defenestration commences. 
LSEC defenestration has been shown to occur early in the pathogenesis of cirrhosis in 
patients suffering from chronic alcohol abuse (Horn et al, 1987), accompanied by 
hyperlipoproteinemia (Clark et al, 1988).  LSEC defenestration also occurs in animal 
models of cirrhosis (Le Couteur et al, 2005; Nopanitaya et al, 1976).  
 
Nicotine, fed to rats at a weight adjusted dose equivalent to that of a human smoking 
50 to 100 cigarettes per day for 6 weeks, decreased LSEC porosity to about 40% that 
of control animals and induced hypercholesterolemia (Fraser et al, 1988).  
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1.5.3. Exposure to agents present occasionally in the environment  
 
The hepatic carcinogen dimethylnitrosamine, which is found in processed meat, 
induces defenestration (Fraser et al, 1995). The detergent poloxamer-407 induces loss 
of LSEC porosity by decreasing the fenestration frequency with no changes in ATP or 
mitochondrial function, and with marked associated hyperlipidemia (Cogger et al, 
2006).  
 
1.5.4. Pathophysiologic processes 
 
Cirrhosis and ageing are also associated with marked structural changes in the 
sinusoidal endothelium and space of Disse that influences bulk plasma transfer into 
the space of Disse, through the LSECs (Le Couteur et al, 2005). Capillarization 
associated with cirrhosis differs from ageing-associated pseudo-capillarization by 
having additional features of bridging fibrosis or nodular regeneration, periportal or 
pericentral fibrosis, loss of hepatocyte microvilli, and only minor deposits of collagen 
in the space of Disse. These changes impede the transfer of many substrates including 
chylomicron remnants, albumin, protein-bound drugs and other macromolecules to 
the hepatocytes via the space of Disse (Le Couteur et al, 2002). 
 
Paracetamol overdose dilates fenestrations and causes the generation of large gaps 
(Walker et al, 1983). The hepatic carcinogen dimethylnitrosamine, which is found in 
processed meat, induces defenestration (Fraser et al, 1995). Post-hepatic inferior vena 
cava occlusion dilates fenestration diameter to drastic proportions, while decreasing 
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the fenestration frequency (Nopanitaya et al, 1976). Artificial high perfusion pressure 
through the hepatic portal vein simulating portal hypertension dilates fenestrations 
and also results in the trapping of large chylomicrons (Fraser et al, 1980). This 
particular study also suggests a possible mechanism in the hepatic steatosis seen in the 
"nutmeg liver" of chronic venous congestion. 
 
Though diabetes mellitus is associated with extensive vascular pathology, very little is 
known about its long-term effects on the liver sinusoid and its fenestrations. Possible 
ultrastructural liver sinusoidal changes are important because of the role of LSEC 
fenestrations on the hepatic disposition of lipoproteins. The vascular complications of 
diabetes are well established and are clinically significant (Singleton et al, 2003). In 
old age, there is a substantial loss of fenestrations in the LSEC (Cogger et al, 2003; Le 
Couteur et al, 2001; McLean et al, 2003; Warren et al, 2005), which impairs 
lipoprotein transfer to the hepatocyte (Hilmer et al, 2005). Clearly, there are potential 
parallels between age-related dyslipidemia and diabetes mellitus-related dyslipidemia 
(Adiels et al, 2006; Battula et al, 2000; Mamo et al, 1993). It will be interesting to 
determine whether diabetes mellitus influences liver sinusoidal fenestrations because 
of potential mechanistic implications for diabetic dyslipidemia.  
 
Alterations in fenestration number, frequency, distribution, and diameter by 
hormones, xenobiotics, hepatotoxins, and diseases have important ramifications for 
hepatic microcirculation, substrate handling, drug metabolism, and overall function. 
Chylomicrons (100- 1000 nm diameter) are too large to pass through the fenestrations 
(Naito and Wisse, 1978). Only partially catabolised chylomicrons (chylomicron 
remnants) attain individual dimensions small enough to pass through the fenestrations 
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into the space of Disse (Fraser et al, 1978; Le Couteur et al, 2002). In defenestration 
seen in cirrhosis (Clark et al, 1988; Fraser et al, 1995; Le Couteur et al, 2005), normal 
ageing (Cogger et al, 2003; Hilmer et al, 2005; Le Couteur et al, 2005; McLean et al, 
2003) or treatment with the commonly used detergent poloxamer-407 (Cogger et al, 
2006), distribution of chylomicron remnants was excluded from the space of Disse 
(Cogger et al, 2006).  
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Table 1.3. Effect of commonly exposed agents and pathogenic processes on 
LSEC fenestrations 
 Treatment Agent Por % 
Fen 
Diameter 
Fen 
Freq Other Changes Citations 
 
AUTONOMIC AND VASOACTIVE-AGENT REGULATION 
1 Acetylcholine  ↑   
(Tsukada et al, 1986; Wisse et 
al, 1980)
 
2 Noradrenaline  ↓   
(Tsukada et al, 1986; Wisse et 
al, 1980)
 
3 5HT ↓ ↓  
↑Cell Ca2+ 
↑ cAMP Changes 
blocked    by Ca2+ 
chelation or Ca2+ 
channel blocker 
 
(Braet(a) et al, 1995; Gatmaitan 
et al, 1996)
 
4 Endothelin 1  ↓   (Oda et al, 1997) 
5 ETA-R antagonist (BQ123)  ↓ ↓  
(Watanabe et al, 2007) 
6 Prostaglandin E1  ↑   (Oda et al, 1997) 
7 Pantethine ↑ ↑ ↑  (Fraser et al, 1989) 
 
ALCOHOL OR NICOTINE EXPOSURE 
8 Ethanol ↑ ↑ ↑  
(Braet(a) et al, 1995; Charels et 
al, 1986; Fraser et al, 1980; 
Mori et al, 1991; Sarphie et al, 
1997)
 
9 Ethanol (Chronic) ↓  ↓ Hepatic Steatosis 
(Horn et al, 1987; Sarphie et al, 
1997)
 
10 Nicotine ↓ ↓ - Hypercholesterolemia (Fraser et al, 1988) 
 
EXPOSURE TO AGENTS PRESENT OCCASIONALLY IN THE ENVIRONMENT 
11 Dimethylnitrosamine (Processed meat) ↓    
(Fraser et al, 1995) 
12 Poloxamer 407 (Various products) ↓  ↓ 
No ATP changes 
No Mitochondrial 
dysfunction 
(Cogger et al, 2006) 
 
PATHOLOGICAL PROCESSES 
13 Ageing ↓  ↓ 
↓ Mass ↓ Blood flow ↑ 
Endothelial thickening, 
Pseudocapillarization 
(Cogger et al, 2003; Hilmer et 
al, 2005; Le Couteur et al, 2005; 
McLean et al, 2003)
 
14 Cirrhosis ↓  ↓ 
Cirrhotic nodules, 
↑ Endothelial 
thickening, 
Capillarization 
(Clark et al, 1988; Fraser et al, 
1995; Le Couteur et al, 2005; 
Nopanitaya et al, 1976) 
15 Posthepatic Inferior Vena Cava occlusion ↑ ↓ ↑ ↑↑  
(Nopanitaya et al, 1976)
 
16 Portal hypertension ↑  ↑  (Fraser et al, 1980) 
17 Paracetamol overdose  ↑   (Walker et al, 1983) 
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1.6. The Ageing Liver 
 
1.6.1. Effect of ageing on liver, sinusoidal and LSEC morphology 
 
Age-induced liver sinusoidal endothelial changes (pseudocapillarization) include 
increases in endothelial thickness, extra-cellular matrix deposition in the space of 
Disse and decreases in LSEC porosity and fenestration frequency (defenestration) 
(Table. 1.4).  These changes were evident across a range of animal models inclusive 
of rats (Le Couteur et al, 2001), humans (McLean et al, 2003), mice (Warren et al, 
2005), and baboons (Cogger et al, 2003). In the afore-cited studies, the 
ultramicroscopic changes were accompanied by increased von Willebrands factor 
(capillary marker) expression in all species, but increased collagen and laminin 
expression only in humans and rats. Since old age is the pivotal risk factor for most 
diseases including liver disease, studies of the effects of disease on the liver should 
take these age-related changes into consideration. 
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Table 1.4. Effects of ageing on the porosity and thickness of the liver sinusoidal 
endothelium 
 Young Old Fractional Change Citation 
ENDOTHELIAL POROSITY % (SEM) 
Mouse 4.1±2.2 2.2±3.5 0.53 (Warren et al, 2005) 
Rat 4.1±2.3 2.5±1.2 0.61 (Le Couteur et al, 2001) 
Baboon 4.2±0.5 2.4±0.4 0.57 (Cogger et al, 2003) 
Human Not done 
FENESTRATION DIAMETER (nm) (SEM) 
Mouse 74±4 58±12 0.78 (Warren et al, 2005) 
Rat 73±1 60±1 0.82 (Le Couteur et al, 2001) 
Baboon 58±1 70±2 1.20 (Cogger et al, 2003) 
Human Not done 
ENDOTHELIAL THICKNESS (nm) (TEM) 
Mouse 154±4 245±8 1.59 (Warren et al, 2005) 
Rat 230±50 320±80 1.39 (Le Couteur et al, 2001) 
Baboon 130±8 186±9 1.43 (Cogger et al, 2003) 
Human 165±17 289±9 1.75 (McLean et al, 2003) 
 
The effects of old age on porosity %, fenestration diameter (nm) and thickness (nm) 
of the hepatic sinusoidal endothelium across four species. Porosity and fenestration 
diameter were elucidated using scanning electron microscopy (SEM) and endothelial 
thickness using transmisson electron microscope (TEM). Adapted from (Warren et al, 
2005). 
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1.6.2. Functional implications of morphologic changes in the ageing liver.    
 
Research into the ageing process of the liver is of paramount importance because of 
the significant decrease in xenobiotic detoxification by the liver in old age (Le 
Couteur and McLean, 1998), and because the liver is the main site for metabolism of 
many substrates associated with age-related problems such as vascular disease, 
neurotoxicity and adverse drug reactions (Le Couteur et al, 2002; Le Couteur and 
McLean, 1998; Le Couteur et al, 2002). 
 
Old age is associated with reduced clearance of highly atherogenic chylomicron-
remnants from the liver (Krasinski et al, 1990; Weintraub et al, 1996). Experimentally 
it has been demonstrated that age-related pseudocapillarization substantially impedes 
small-lipoprotein transfer across the sinusoidal endothelium (Hilmer et al, 2005).  
Though normal hepatic sinusoidal endothelium provides insignificant resistance to 
oxygen transfer (Kassissia et al, 1992), there is a significant diffusion barrier to 
oxygen diffusion posed by the blood vessels in cirrhosis (Froomes et al, 2003; 
McLean and Morgan, 1991) and in normal capillaries in other organs (Cho et al, 
2001; Rose and Goresky, 1985). It is thus of interest to determine whether age-related 
pseudocapillarization constitutes an oxygen diffusion barrier (Fig. 1.4B) similar to 
that seen in cirrhosis (Le Couteur and McLean, 1998). 
 
Phase 1 hepatic drug metabolism, encompassing  oxidation, reduction or hydrolysis of 
drugs, is diminished in old age (Herrlinger and Klotz, 2001; Kinirons and O'Mahony, 
2004). These age-related changes could be caused by one or more of the following: 
decreased liver perfusion (Schmucker, 2001),  possible oxygen-diffusion barrier 
secondary to age-associated liver pseudocapillarization of the liver sinusoidal 
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endothelial cell (Le Couteur et al, 2001), mitochondrial oxidative stress (Sastre et al, 
2003) or mitochondrial dysfunction (Sastre et al, 1996). The differences between in 
vivo and in vitro assessments of phase I drug metabolism in old age (Herrlinger and 
Klotz, 2001; Kinirons and O'Mahony, 2004), could possibly reflect intrahepatocytic 
hypoxia because oxygen is an essential cofactor for cytochrome P450 enzymes (Le 
Couteur and McLean, 1998). Livers from aged rats have decreased high-energy 
phosphate metabolite pools than those from young rats, suggestive of hypoxia (Le 
Couteur et al, 2001) .  Livers from aged mice have less total ATP than those from 
young mice (Selzner et al, 2007), However, this was associated with diminished 
oxygen consumption and ATP production by isolated mitochondria, which is 
suggestive of mitochondrial dysfunction rather than hypoxia (Selzner et al, 2007). 
There is also an upregulation of several genes and proteins that respond to hypoxia in 
old age (Kang et al, 2005).  
 
These age-related changes in liver high-energy phosphate metabolites and 
oxygenation could be caused by decreased oxygen delivery to hepatocytes secondary 
to either reduced liver perfusion (Schmucker, 2001), or an oxygen-diffusion barrier 
secondary to age-associated “pseudocapillarization” of the liver sinusoidal endothelial 
cell (LSEC) (Le Couteur et al, 2001). Augmenting the latter possibility is a study that 
experimentally induced partial pseudocapillarization via ATP depletion (Braet et al, 
2003). Alternatively, the reduction in ATP might also be secondary to age-related 
mitochondrial oxidative stress (Sastre et al, 2003) or mitochondrial dysfunction 
(Sastre et al, 1996). 
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Figure 1.4. Transmission electron micrograph of livers from young versus aged rats  
Transmission electron micrograph of the liver of a young rat showing a normal liver 
sieve (A) and an old rat showing pseudocapillarization with LSEC defenestration, 
endothelial thickening and basement membrane deposition (B) (Hilmer et al, 2005). A 
conceptual illustration is also depicted in this figure (C) (Le Couteur et al, 2002). The 
sinusoidal endothelium is thin and perforated with fenestrae, which permit the passage 
of substrates such as smaller lipoproteins, while excluding larger substrates such as 
chylomicrons. In old age, the endothelium is defenestrated and thickened, with 
deposition of collagen and basal lamina. These changes (pseudocapillarization) will 
impede the transfer of substrates between sinusoidal blood and hepatocytes. (S= 
Sinusoidal Space, A= Chylomicron, E= Endothelium, B= Basement membrane, D= 
Space of Disse, H= Hepatocyte) 
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1.6.3. Stategies to delay ageing- calorie restriction 
 
The outcomes of age-related impairment in liver function are well recognized (Le 
Couteur et al, 2005; Schmucker, 2005). One mechanism for this change is age-related 
alterations in the ultrastructure of the liver sinusoidal endothelium (Le Couteur et al, 
2005). The loss of fenestrations in old age, which is part of pseudocapillariation, 
impedes the transfer of some lipoproteins from the blood to the hepatocytes, which 
provides a mechanism for age-related postprandial hypertriglyceridemia and impaired 
chylomicron remnant clearance (Hilmer et al, 2005; Huet and Villeneuve, 2005).  
 
Caloric restriction (CR) increases longevity and the pathophysiological processes 
which are delayed by CR are considered to be an integral part of the ageing process 
(Ingram et al, 2004; Masoro, 2005; Sinclair, 2005). Reduction in the intake of calories 
delays the onset of age-related diseases and increase maximum lifespan by between 
20% and 40% in many species (Everitt et al, 2005). CR improves lipoprotein profiles 
and delays the onset of vascular disease in animal models (Zhu et al, 2004), with 
similar effects observed in short term studies in humans (Heilbronn et al, 2006). 
 
It is plausible that one mechanism for the effects of CR on lipoprotein metabolism and 
susceptibility to vascular disease may pertain to its effects on the liver sinusoidal 
endothelium and its fenestrations (Le Couteur et al, 2001). The liver sinusoidal 
endothelium is exquisitely sensitive to oxidative stress (Cogger et al, 2001; Cogger et 
al, 2004) and other toxic insults (McCuskey, 2006). Thus, it is possible that its 
ultrastructure may be influenced profoundly by the dietary load, which includes 
oxidants and toxins delivered to the liver via the portal vein. Since age-related hepatic 
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pseudocapillarization may contribute to the pathogenesis of dyslipidemia and since 
CR is a powerful model for the study of ageing as it extends lifespan, it will be 
interesting to determine whether pseudocapillarization is preventable and hence 
unravel a possible novel target for the prevention of age-related dyslipidemias.  
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1.7. Immunological functions of the liver: Focus on hepatic immune response to 
gram negative bacterial toxins 
 
1.7.1. Introduction 
 
The liver contains many immunologically active cells including KCs, LSECs and 
neutrophils and lymphocytes, and perhaps the hepatocytes themselves (Kmiec, 2001; 
Knolle and Gerken, 2000). The liver acts as a filter or a 'sieve' for bacteria and 
antigens carried to it via the portal tract from the gastrointestinal tract (GIT). These 
antigens are phagocytosed and degraded by KCs, which are modified macrophages 
attached to the endothelium (Wake et al, 1989). The near lack of lymphoid tissue 
implies that antigens are degraded without the production of antibody (Kmiec, 2001; 
Knolle and Gerken, 2000). The antigens are thus precluded from reaching other 
antibody-producing sites in the body, thereby preventing adverse systemic 
hypersensitivity. The liver favors the induction of tolerance rather than the induction 
of immunity (Kmiec, 2001; Knolle and Gerken, 2000). Different liver cell types may 
contribute in a myriad of ways to induce liver antigenic tolerance. These may include 
control of antigen presentation (immune ignorance), clonal deletion and immune 
deviation. Naive T cells are activated by LSECs, but do not differentiate into effector 
T cells. These T cells demonstrate a functional phenotype and cytokine induction 
profile typical of tolerance induction (Knolle et al, 1999). Dendritic cells (DCs), 
LSECs, KCs and hepatocytes also contribute to tolerance induction by deletion of T 
cells through induction of apoptosis (Knolle and Gerken, 2000). 
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1.7.2. Kupffer cells 
 
The liver filters bacteria and antigens that come from the gastrointestinal tract via the 
portal vein. These antigens are phagocytosed and degraded by KCs, which are 
predominantly located in the periportal area. The KCs assist in tissue repair, T and B 
lymphocyte interaction, and cytotoxic activity in disease processes (Schumann et al, 
2000). KCs have specific membrane receptors for ligands, and are activated by 
several factors such as infection (Scoazec and Feldmann, 1990). They secrete 
interleukins, tumor necrosis factor-α (TNF-α), collagenase and lysosomal hydrolases. 
KCs are Antigen Presenting Cells (APCs), which modulate immune responses, oral 
tolerance development to bacterial superantigens, and suppression of T-cell activation 
by antigen-presenting LSECs, prostanoids and TNF-α (Knolle and Gerken, 2000; 
Schumann et al, 2000). They play a pivotal role in the clearance of senescent and 
damaged erythrocytes. KCs are also involved in neutrophil adhesion and migration in 
the hepatic sinusoids during liver injury. This is mediated through TNF-α production 
in KCs and Inter Cellular Adhesion Molecule-1 (ICAM-1) expression in LSECs 
(Jaeschke, 1997; Sakamoto et al, 2002). 
 
During acute hepatic insult, KCs secrete enzymes and cytokines that damage 
hepatocytes, and are active in the remodeling of Extracellular Matrix (ECM). 
Following LPS stimulation, KCs release IL-6, IL-8 and TNF-α, which induce liver 
parenchymal damage. These cytokines also stimulate LSECs, stellate cells and natural 
killer cells to release pro-inflammatory cytokines, thus exacerbating the damage 
(Kmiec, 2001).  
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Exposure of KCs to LPS can lead to intensive inflammatory mediator production, and 
subsequently, liver injury. KCs are involved in the initial hepatic insult, followed by 
neutrophils in the latter phase of hepatic injury (Jaeschke and Farhood, 1991; 
Jaeschke et al, 1996), both of them utilizing reactive oxygen species (ROS) to effect 
the injury (Jaeschke, 2002; Jaeschke and Farhood, 1991; Jaeschke et al, 2002).   
 
Alcohol increases gastrointestinal tract permeability, liberating LPS from gut bacteria 
into the blood stream, which stimulates KCs. KCs and gastrointestinal tract-derived 
LPS are crucial in the pathogenesis of alcohol induced hepatotoxicity (Enomoto et al, 
2000). Long-term alcohol exposure changes KC sensitivity to LPS (Enomoto et al, 
2001).  
 
TNF-alpha plays a critical role in the pathogenesis of hepatic injury in response to 
LPS.  Leukotriene D4 and ROS induction seem to precede TNF-α action in the 
induction of LPS-induced hepatitis in the murine endotoxin/ galactosamine TNF-α 
model (Tiegs and Wendel, 1988; Tiegs et al, 1989). Thus, TNF-α is a crucial 
mediator secreted by KCs in LPS induced LSEC apoptosis (Takei et al, 1995). 
Granulocyte-colony stimulating factor (G-CSF) is a negative feedback signal for 
macrophage-derived TNF-α production after LPS induced hepatotoxicity (Gorgen et 
al, 1992). Thalidomide prevents KC mediated LPS-induced liver injury via 
suppression of TNF-α secretion from KCs (Enomoto et al, 2003). 
 
P. aeruginosa exotoxin A induces liver damage not only by inhibition of protein 
synthesis but also by indirectly stimulating TNF-α secretion by KCs (Schumann et al, 
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1998). In order to induce rapid hepatocyte necrosis and apoptosis, P. aeruginosa 
Exotoxin A requires the presence of T cells to stimulate KCs to secrete TNF-α 
(Schumann et al, 1998; Schumann et al, 2000). 
 
In hepatic reperfusion injury, KCs are the predominant cause of initial hepatic 
damage, which is mediated through ROS (Jaeschke and Farhood, 1991). However, 
neutrophils mediate the pathogenesis of later progression phase of hepatic 
ischaemia/reperfusion injury (Jaeschke and Farhood, 1991; Jaeschke et al, 1990). 
 
1.7.3. Neutrophils 
 
In endotoxin mediated liver injury, KCs are involved in the initial insult, followed by 
neutrophils in the latter phase of hepatic injury (Jaeschke et al, 1996), both using ROS 
to effect the damage (Jaeschke, 2002; Jaeschke et al, 2002; Liu et al, 1995). Though 
the significance of the prominent presence of neutrophils in liver parenchyma during 
alcoholic hepatitis is not clear, the presence of neutrophil degranulation and 
chemotactic agent release point to the crucial role of neutrophils in the pathogenesis 
alcoholic hepatitis. In addition, apoptosis-induced transmigration of neutrophils 
during alcoholic hepatitis is certain owing to colocalization between neutrophils and 
apoptotic hepatocytes (Jaeschke, 2002). Neutrophils play a crucial role in the 
pathogenesis of the later progressive phase of hepatic ischaemia/reperfusion injury 
(Jaeschke et al, 1990). 
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1.7.4. Lymphocytes 
 
Mucosal lymphocytes migrate towards the site of hepatic insult. LSECs regulate the 
recruitment of specific lymphocyte subtypes (Klugewitz et al, 2002). LSECs suppress 
IFN-  producing cell expansion. Alternatively, they prime IL-4-expressing Th2 cells, 
creating immune suppression in the liver. Antigen presentation in the liver therefore 
promotes modulation of immunity (Klugewitz et al, 2002). Adhesion molecule 
expression and chemokines initiate lymphocyte adhesion. Many adhesion molecules 
and chemokines are necessary for lymphocyte endothelial binding as enumerated 
elsewhere (Lalor and Adams, 1999; Lalor et al, 2002). Circulation of sustained high 
concentrations of TNF-α, which depends on the presence of T cells, is peculiar 
feature of synergistic P. aeruginosa Exotoxin A  with LPS-induced hepatotoxicity 
(Schumann et al, 2000). LPS suppresses Ag-specific immune responses by CD4+ T 
cells by antigen-presenting LSECs (Knolle et al, 1999).  
 
1.7.5. LSECS: Overall contribution to liver immunology  
 
LSECs are crucial to antigen processing, scavenging and tolerance induction to GIT 
and systemic antigens. LSECs constitutively express all molecules necessary for 
antigen presentation (CD40, CD54, CD80, CD86, MHC-I and MHC-II) and function 
as MHC-I and MHC-II restricted antigen-presenting cells (APC) (Kmiec, 2001; 
Knolle and Gerken, 2000; Knolle et al, 1999; Scoazec and Feldmann, 1991). LSECs 
exhibit antigenic resemblance to dendritic cells by expressing CD4, the mannose 
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receptor and CD 11C (Knolle et al, 1999; Knolle et al, 1998; Magnusson and Berg, 
1989; Scoazec and Feldmann, 1990). LSECs are very good antigen presenting cells 
and have been shown to induce proliferation of, co-stimulate, and upregulate cytokine 
production in CD4+ T Cells (Knolle et al, 1998; Lohse et al, 1996)..  
 
LSECs regulate the recruitment of specific lymphocyte subtypes. CD4 and CD8 T 
cells that simultaneously interact  with LSECs have a tolerant phenotype (Knolle and 
Limmer, 2003). They suppress IFN-  producing cells and promote IL-4-expressing 
helper T cell subset 2 (Th2) cells cells, creating immune suppression in the liver 
(Klugewitz et al, 2002). LSEC primed CD4+ T cells differentiate into regulatory T 
cells, whereas myelocytic APC primed T cells differentiate into helper T cell subset 1 
(Th1) cells (Limmer and Knolle, 2001).  Therefore, LSEC primed CD4+ T cells play 
a crucial role in tolerance induction in the liver. The CD4+ T cells priming activity of 
LSECs can be negatively regulated by prostaglandin E2 (PGE2) and interleukin-10 
(Knolle et al, 1998). LSECs also play a role in the development of tolerance by CD8 
T cells towards orally adminsistered antigens (Limmer et al, 2005). LSECs are also 
important in tolerance induction in liver transplantation. In one study, the rejection of 
donor livers correlated closely with the presence of anti-LSEC antibodies, increased 
activation of T cells and decreased TGF-β (Sumitran-Holgersson et al, 2004). 
 
In addition to the antigen processing, LSECs scavenge antigens such as LPS and 
advanced glycation end products (Knolle and Limmer, 2003; Shnyra et al, 1993; 
Shnyra and Lindberg, 1995; Smedsrod et al, 1990). Scavenging is distinctly different 
from antigen processing. LSECs endocytose glycoproteins, extracellular matrix 
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components, immune complexes, transferrin and ceruloplasmin, thereby clearing 
antigens from the vasculature (Svistounov and Smedsrod, 2004).  
 
LSECs may assist immune surveillance via T cell activation, which in turn is 
influenced by the milieu encompassing bacteria and LPS. LSECs express CD14, the 
LPS-Binding protein receptor (Gong et al, 2002; Scoazec and Feldmann, 1991). 
LSECs may also assist immune surveillance by releasing immunosuppressive 
mediators such as interleukin-10, prostaglandin E2 and transforming growth factor- 
(TGF-) (Knolle and Gerken, 2000; Knolle et al, 1998; Sumitran-Holgersson et al, 
2004). LSECs secrete several vasoactive substances and eicosanoids such as 
cytokines, prostanoids, leukotrienes, endothelin-1 and nitric oxide (Knolle and 
Gerken, 2000).  
 
1.7.6. LSECS and lipopolysaccharide 
 
Lipopolysaccharide (LPS or bacterial endotoxin) is a secreted by most gram-negative 
bacteria including P. aeruginosa. LPS is present in normal portal blood at high 
physiological concentrations of 10 pg/ml to 1 ng/ml (Knolle and Gerken, 2000). One 
study done on samples collected from 21 patients with cirrhosis using a limulus-based 
chromogenic assay, estimated the portal venous LPS concentrations to be 142 ± 167 
pg per ml in contrast to the peripheral venous LPS concentration of 82 ± 150 pg per 
ml (P<0.001) (Lumsden et al, 1988).  In another study done using limulus lysate assay 
on samples from 34 elective abdominal surgery patients, 97% of the patients had LPS 
in their portal blood demonstrating that LPS is present normally in portal blood and is 
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not necessarily pathogenic (Jacob et al, 1977). In this study, systemic endotoxemia 
was observed in 3 of the 4 patients who also had liver disease, and none of the 
patients without liver disease. Therefore, pathological concentrations of LPS seem to 
be present in systemic blood only during gram-negative bacterial sepsis or during 
liver disease (Jacob et al, 1977; Yamamoto et al, 1994).  
 
When LSECs are incubated with physiological concentrations of LPS,  specific 
immune responses by CD4+ cells are down-regulated (Knolle et al, 1999). LPS also 
induces LSEC scavenger and endocytotic functions (Shnyra et al, 1993) and 
subsequently antigen presentation to lymphocytes (Knolle et al, 1998; Lohse et al, 
1996). LPS can also induce LSEC apoptosis via TNF secreted by KCs (Takei et al, 
1995). 
 
LPS defenestrates LSECs (Fraser et al, 1995). One intravenous dose of LPS (2 mg/kg 
body weight) in Dark-Agouti rats reduced LSEC porosity significantly, the changes 
being spontaneously reversed after 14 days. With the same LPS dose, Sprague-
Dawley rats showed similar but irreversible changes at-least 3 days after LPS 
challenge (Dobbs et al, 1994). Intravenously injected LPS (2.5 mg/kg body weight) in 
F344 rats resulted in LSEC enlargement, sieve plate disruption and gap formation 6 
hours after LPS challenge (Seto et al, 1998). KCs seem to modulate LPS-induced 
LSEC defenestration and impaired hyaluronan scavenging (Sarphie et al, 1996). Takei 
and co-workers reported that co-incubation of LSECs with LPS-stimulated KCs 
induces significant apoptosis in LSECs that are in contact with KCs, and that anti-
TNF-α antibody prevents this (Takei et al, 1995).  
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Alcohol abuse may promote the uptake of LPS from alcohol lysed gut bacteria or 
from direct injury to the intestinal wall (Enomoto et al, 2000) . LPS could possibly 
induce liver damage, starting with the LSEC (Dobbs et al, 1994) or secondary to 
Kupffer cell and neutrophil (Enomoto et al, 2000; Jaeschke et al, 1996) activation. 
This could be a pivotal pathogenic factor in alcoholic cirrhosis. 
 
1.7.7. LSECS and Pseudomonas aeruginosa  
 
P. aeruginosa is a common nosocomial bacterial pathogen associated with a high 
incidence of morbidity and mortality in acute cases (Gouvea et al, 2004). Post-
operative pseudomonal infections, including P. aeruginosa infections after liver 
transplantation (Gouvea et al, 2004; Iinuma et al, 2004; Korvick et al, 1991; Singh et 
al, 2004) can result in sepsis (Hart et al, 2003; Hart et al, 2003), bacteremia (Iinuma et 
al, 2004; Singh et al, 2004), hepatic damage (Muhlen et al, 2004; Schumann et al, 
2000) and fatal multiple-organ failure (Hart et al, 2003; Hart et al, 2003). The few 
studies which describe the P. aeruginosa as one of the commonest multi-antibiotic 
resistant nosocomial organisms, especially in post-surgical and post-liver transplant 
scenarios, are tabulated in Table. 1.4 below. 
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Table 1.5. Incidence of P. aeruginosa in post-surgical and post-liver 
transplant infections 
 
Study 
Dates 
Patient 
Cohort 
Cohort 
Size 
Pathogen 
Parameter 
Examined 
Cohort %  
with 
Parameter 
Present 
Incidence of 
Pseudomonal 
Infections 
Pathology 
Specifics Citations 
2000-
2003 
Liver 
transplant 30 Bacteremia 30% 44% of bacteremia 
100 % with 
bacteremia 
died 
(Doria and Marino, 
2005)
 
1999- 
2003 
Liver 
transplant 103 
Bacterial 
pneumonia 32% 17% of pneumonia 
50% with 
pneumonia had 
acute rejection 
(Ma et al, 2005)
 
1989-
2003 
Liver 
transplant 233 Bacteremia 52% Topmost  
(Singh et al, 2004)
 
2001- 
2002 
Living 
donor 
liver 
transplant 
113 Surgical site infection 37% 
33 % of Gram 
negative bacterial 
infections 
26% with 
surgical site 
infection died 
(Iinuma et al, 2004)
 
1999- 
2002 
Liver 
transplant 99 
Multiple 
antibiotic 
resistance 
57% 23% of all bacterial infections 
63% of all 
infections by 
multi-antibiotic 
resistant 
bacteria 
(Gouvea et al, 2004)
 
1998-
2001 
Liver 
transplant 401 Pneumonia 5% 
>57% of 
pneumonia  
(Aduen et al, 2005)
 
1990- 
1999 
Liver 
transplant 165 
Multiple 
antibiotic 
resistance 
31% 
50% of multi-
antibiotic resistant 
bacteria 
Higher 
mortality 
(Singh et al, 2001)
 
1995-
1998 
Liver 
transplant 
in ICU 
90 Pulmonary infiltration 40% 27% of pneumonia 
38% with 
infiltrates had 
pneumonia 
(Singh et al, 1999)
 
1990- 
1995 
Liver-
lung-heart 
transplant 
in Cystic 
Fibrosis 
10 
Double 
organ 
transplants 
 100% 
100% Multi- 
antibiotic 
resistant 
(Couetil et al, 1995)
 
1990-
1993 
Liver 
transplant 284 
Aerobic 
gram –ve 
bacteria 
45% 
Most frequently 
isolated from 
blood 
 
(Wade et al, 1998)
 
1988- 
1991 
Liver 
transplant 185 
Bacteremia 
& fungemia 29% 
10% of 
bacteremias & 
fungemias 
95% of all 
infections 
nosocomial 
(Moreno et al, 1994)
 
1985-
1991 
Kidney 
transplant 568 
Bacteremia 
& fungemia 11% 
19% Bacteremias 
& fungemias 
70% of all 
infections 
nosocomial 
(Moreno et al, 1994)
 
1981- 
1984 
Liver 
transplant 129 
Early death> 
24 hours 37% 
53% of deaths due 
to bacterial sepsis 
Bacterial sepsis 
in 81% of 
deaths 
(Cuervas-Mons et al, 
1986)
 
 
 53 
Pyocyanin, a redox active, pro-inflammatory, pro-apoptotic, cytotoxic and 
immunomodulating phenazine dye is secreted in copious quantities by Pseudomonas 
aeruginosa. Though systemic, portal or hepatic concentrations of pyocyanin have not 
been estimated in Pseudomonal sepsis, it is well known that it is produced in large 
amounts (up to 130 µM) in respiratory secretions from cystic fibrosis and 
bronchiectasis patients with P. aeruginosa infections (Pitt, 1986; Wilson et al, 1987; 
Wilson et al, 1988).  
 
Pyocyanin has been shown to exert its in vivo cytotoxicity by impairing the cellular 
redox status and depleting intracellular GSH and thiols in endothelial cells (Muller, 
2002) and transformed epithelial cells (O'Malley et al, 2004) via superoxide and H2O2 
generation (Muller, 2002; O'Malley et al, 2004), or through direct oxidation of GSH 
(O'Malley et al, 2004). Pyocyanin may possibly induce induce sinusoidal H2O2, which 
may then enter the cell, inducing modifications in the cellular actin cytoskeleton 
leading to altered LSEC morphology.  
 
1.7.8. Hepatic immune response to gram negative bacterial toxins  
 
The liver is the first organ which encounters pathogens or pathogen products from the 
gut. Alcohol-induced gut permeability dependent mechanisms liberate LPS from 
gastrointestinal gram negative bacteria (Enomoto et al, 2000). Alcohol decreases the 
usual endotoxemia- induced increased glucose production and uptake  via inhibition 
of hepatic glucose production and peripheral glucose utilization (Molina et al, 1989). 
Burns sensitize KCs to LPS via gut-derived LPS dependent mechanisms (Enomoto et 
al, 2004). Gram negative bacterial sepsis or liver disease can lead to the presence of 
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high concentrations of systemic and portal LPS (Jacob et al, 1977). As documented in 
the 1.7.2. section on Kupffer cells, exposure of KCs to LPS leads to intensive 
inflammatory mediator production, adhesion molecule expression, neutrophil 
chemotaxis and activation, and subsequent LSEC and hepatocyte injury. These 
findings suggest that LPS-induced structural changes in the liver sinusoid are 
mediated by LPS-induced Kupffer cell activation. Exposure of LSECs to LPS induces 
defenestration (Fraser et al, 1995) and the LSEC functions of scavenging (Shnyra and 
Lindberg, 1995), endocytosis (Shnyra and Lindberg, 1995) and antigen presentation 
to lymphocytes (Knolle et al, 1998; Lohse et al, 1996). LPS induces LSEC apoptosis 
via TNF secreted by KCs (Takei et al, 1995). LPS alters the membrane fluidity of 
hepatocytes (Salgia et al, 1993). LPS may influence hepatocyte-macrophage 
communications (Ogle et al, 1995) and in humans lead to a transient increase in liver 
insulin-like growth factor (IGF) in addition to transient increases in cortisol  and 
pituitary growth hormone, similar to changes seen in acute trauma (Lang et al, 1997). 
In the isolated perfused rat liver model, LPS induces cholestasis without significant 
hepatic damage which suggests a possible role for extrahepatic mechanisms for 
induction of liver damage (Gaeta and Wisse, 1983).  
 
Leukotriene D4 and ROS induction seem to precede TNF-α action in the induction of 
LPS-induced hepatitis (Tiegs and Wendel, 1988; Tiegs et al, 1989). Granulocyte-
colony stimulating factor (G-CSF) is a negative feedback signal for macrophage-
derived TNF-α production after LPS induced hepatotoxicity (Gorgen et al, 1992). 
Superoxide generation in the hepatic sinusoid in response to LPS challenge is likely to 
be a factor involved in liver damage (Yokoyama et al, 1998). LPS is a potent 
stimulator of hepatocyte fibronectin which suggests that hepatocytes may also be 
 55 
directly involved in liver fibrosis (Jia et al, 1998). In one murine model study, co-
administration of non-hepatotoxic doses of the commonly used H2-blocker ranitidine 
and LPS activated the clotting system via over expression of plasminogen-activator 
inhibitor-1 (PAI-1), with fibrin deposition in the liver and hepatocyte damage 
(Luyendyk et al, 2004; Luyendyk et al, 2004). Thrombin is a promoter (Copple et al, 
2003) and a distal mediator (Moulin et al, 1996) of LPS induced hepatotoxicity. LPS 
induces decreased LSEC thrombomodulin which results in sinusoidal microthrombus 
formation and exacerbation of hepatic injury (Kume et al, 2003). Platelets (Pearson et 
al, 1995) and the coagulation cascade (Hewett and Roth, 1995) contribute to LPS 
induced hepatic injury. KCs play an important role in LPS induced sinusoidal 
thrombogenesis, fibrin degradation and deposition (Takeuchi et al, 1994). LPS also 
synergizes with monocrotaline (Yee et al, 2003), aflatoxin B1(Luyendyk et al, 2003), 
polychlorinated biphenyls (Brown et al, 1996) and a range of liver toxins like carbon 
tetrachloride, ethanol, cadmium, halothane and allyl alcohol (Roth et al, 1997) in 
causing hepatic injury.  
 
Most antioxidant mechanisms are upregulated by LSECs in response to LPS including 
H2O2-detoxifying capacity (Spolarics et al, 1996), LSEC GSH efflux mechanisms 
(Jaeschke, 1992), glucose transporter 1 (GLUT1), glucose-6-phosphate 
dehydrogenase (G6PD) (Spolarics and Navarro, 1994), superoxide dismutases 
(SODs), and glutathione peroxidase (GPx) (Spolarics, 1998). In cirrhosis, there is 
augmented LPS uptake by the liver and increased biliary excretion of LPS (Ueno, 
1990).   
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P. aeruginosa exotoxin A induces liver damage by protein synthesis inhibition, 
activation of KCs to produce TNF-α, and perforin-dependent, Fas-independent, 
apoptotic pathways (Schumann et al, 1998). To induce substantial hepatocyte damage, 
P. aeruginosa exotoxin A requires the presence of T cells to stimulate KCs to secrete 
TNF-α (Schumann et al, 1998; Schumann et al, 2000). For P. aeruginosa exotoxin A 
to synergize with LPS to induce severe hepatotoxicity, T cells are required to produce 
circulation of sustained high concentrations of TNF-α (Schumann et al, 2000). 
 
P. aeruginosa pyocyanin exerts LSEC cytotoxicity by impairing the cellular redox 
status via generation of H2O2, which probably depletes intracellular GSH and thiols in 
endothelial cells (Muller, 2002) and may cause defenestration and its consequences.   
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1.8. Hypertriglyceridemia of sepsis, bacteremia and gram-negative bacterial 
toxemia 
 
Sepsis is associated with free radical induction (Rose et al, 1994), altered redox 
balance (Hart et al, 2003; Hart et al, 2003; Pedersen et al, 1989), cellular NADH/ ATP 
reduction (Hart et al, 2003), cellular cytoskeletal modifications and decreased hepatic 
energy metabolism (Hart et al, 2003; Hart et al, 2003; Spitzer et al, 1989; Spitzer et al, 
1988). Strikingly similar changes can also be induced by gram negative bacterial 
toxins, either LPS (Bannerman and Goldblum, 1999; Jaeschke, 1992; Liu et al, 1995; 
Spolarics, 1996; Yokoyama et al, 1998) or pyocyanin (Britigan et al, 1992; Harman 
and Macbrinn, 1963; Hassett et al, 1992; Landau et al, 1963; Mahajan-Miklos et al, 
1999; Muller, 2002; Muller and Sorrell, 1997; O'Malley et al, 2004; Ran et al, 2003; 
Stewart-Tull and Armstrong, 1972) alone. Conditions including the presence of free 
radicals and cytoskeletal modifying agents are particularly conducive to LSEC 
defenestration.  
 
It is possible that LSEC defenestration induced by bacterial toxins such as LPS or 
pyocyanin may impede hepatic uptake of chylomicron remnants and increase their 
circulation time, leading to the hyperlipidemia of sepsis reported often in literature 
(Harris et al, 2000; Scholl et al, 1984).  The currently accepted hypothesis for 
pathogenesis of sepsis associated hypertriglyceridemia is that sepsis stimulates 
catecholamine release which stimulates release of free fatty acids (FFAs) from 
adipose tissue. The FFAs are taken up by the liver which then releases them as 
triglycerides in lipoproteins (Harris et al, 2000; Spitzer et al, 1988). Alternatively, 
sepsis stimulated TNF-α and IL-1 may suppress lipoprotein lipase (LPL) synthesis, 
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which decreases the rate of triglyceride clearance, leading to hypertriglyceridemia 
(Harris et al, 2000; Spitzer et al, 1988). Both LPS injection and E. coli bacteremia in 
rats result in hypertriglyceridemia and decreased LPL activity.  Experimental sepsis 
stimulates liver putrescine and spermidine synthesis in addition to ornithine 
decarboxylase activation, responses that can also be simulated by LPS and pro-
inflammatory cytokines (Tiao et al, 1995). Therefore it is clear that not only sepsis, 
but also recurrent gram negative infections, bacteremia and toxemia can lead to 
hypertriglyceridemia.  
 
During endotoxemia states, one third of LPS binds to high-density lipoproteins (HDL) 
and is taken up into peripheral tissues. The remaining two thirds are taken up more 
rapidly by predominantly in reticuloendothelial organs with copious phagocytes, 
APCs and cells with scavenger function (Munford and Dietschy, 1985; Munford et al, 
1981). The tissues by which LPS is taken up and the proportion of LPS taken up 
depends upon LPS-HDL binding parameters (Munford et al, 1981). Increased serum 
HDL and its LPS-binding capacity may serve to protect against LPS induced damage 
in chronic alcohol exposure (Kitano et al, 1996; Kitano et al, 1996).  
 
It has been shown that triglyceride-rich lipoproteins including very low density 
lipoproteins (VLDL) and chylomicrons bind LPS.  They form lipoprotein-LPS 
complexes or chylomicron-LPS complexes, modulate the host immune responses and 
therefore impede LPS-induced toxicity (Harris et al, 2000). Chylomicron-LPS 
complexes inhibit nitric oxide release by hepatocytes much better than either of them 
alone, suggesting that chylomicron bound LPS inhibits hepatocyte NF-κB and 
prevents liver damage (Kumwenda et al, 2002). Lipoproteins have also been shown to 
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protect animals from lethal polymicrobial gram-negative bacterial sepsis. Therefore it 
is possible that hypertriglyceridemia could be an innate immune response to gram 
negative sepsis (Read et al, 1995). Alternatively, it could also be a possible 
mechanism to perpetuate LPS-induced toxicity owing to prolonged systemic LPS 
persistence.  
 
In this thesis, an additional mechanism is proposed which could account for the 
hypertriglyceridemia of sepsis. LSEC defenestration in gram negative bacterial 
(including pseudomonal) sepsis induced by toxins such as LPS (Fraser et al, 1995) 
may exclude lipoproteins and chylomicron remnants from the liver. This could lead to 
retention of lipoproteins and chylomicron remnants in the peripheral vasculature 
leading to hyperlipidemia (Fig. 1.5).  
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Figure 1.5. Hypothesised pathogenesis of hyperlipidemia related to pseudomonal 
sepsis 
 
LSEC defenestration in bacterial/ pseudomonal sepsis owing to toxins like pyocyanin 
or LPS may exclude chylomicron remnants from the liver. This could lead to retention 
of lipoproteins in the peripheral vasculature leading to Pseudomonal sepsis-related 
hyperlipidemia. 
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1.9. Conclusions and hypotheses 
 
LPS- or pyocyanin-induced LSEC defenestration may impede hepatic chylomicron 
remnant uptake, increasing the circulation time of chylomicron remnants (Cogger et 
al, 2006; Hilmer et al, 2005) leading to the hyperlipidemia (Fig. 1.5) seen frequently 
in sepsis (Harris et al, 2000; Scholl et al, 1984). The effect of pyocyanin or LPS on 
LSEC fenestrations is likely to be different between young and old animals as healthy 
old animals exhibit decreased porosity and fenestration density (Le Couteur et al, 
2001). Differences in LSEC fenestration status may at least partly account for the 
increased mortality that has been reported in sepsis in older patients. 
 
Contraction of fenestrations is associated with Ca2+ influx (Gatmaitan et al, 1996). 
Endotoxemia alters Ca2+ homeostasis, with minute Ca2+ flux alterations (Deaciuc and 
Spitzer, 1987). These changes, possibly due to catecholamine mediated Ca2+ influx, 
are reversible by Ca2+ channel blockers (Sayeed and Maitra, 1987). Under induced 
endotoxemia, Ca2+ channel blockers limit hepatocyte injury and inhibit LPS-induced 
KC inducible nitric oxide synthase expression (Mustafa and Olson, 1999). LPS 
induced membrane fluidity of hepatocytes can be prevented by Ca2+ channel blockers 
(Salgia et al, 1993). Ca2+ channel blockers may also curb the sepsis induced acute 
phase response by preventing sepsis-related hepatic Ca2+ changes (Rose et al, 1994) 
that lead to reorganization of fenestrations, and so modulate the metabolic response.  
 
Pyocyanin or LPS can trigger oxidant stress. This can lead to an increased sinusoidal 
efflux of GSH and its extracellular oxidation. GSH is depleted in LPS mediated 
hepatic injury (Jaeschke, 1992). Animal models have shown that antioxidants such as 
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GSH (Liu et al, 1994) and adequate nutrition (Wojnar et al, 1995) are protective in 
septic shock. Superoxide generation in the  hepatic sinusoid in response to LPS 
challenge is likely to be a factor involved in liver damage (Yokoyama et al, 1998). 
Superoxide dismutase (SOD), which dismutates superoxide to H2O2 has been shown 
to offer protection against LPS induced liver injury (Rose et al, 1994). Modifying the 
response of LSEC porosity to LPS and P. aeruginosa pyocyanin with calcium channel 
blockers, anti-TNF-α antibody, G-CSF, VEGF, HGF, GSH, N-acetyl cysteine (NAC), 
SOD, and catalase could offer novel therapeutic targets in acute sepsis, especially 
sepsis caused by P. aeruginosa. 
 
It has been clearly demonstared that fenestrations can be regulated with a variety of 
pharmacological agents (Arias, 1990; Braet and Wisse, 2002). Table 1.2 and table 1.3 
clearly summarize these. Morphological changes in liver sinusoidal fenestrations 
seem to have systemic implications particularly for lipoprotein metabolism (Fraser et 
al, 1986), clearance of medications (Le Couteur et al, 2005) and immunity (Warren et 
al, 2006), as well as hepatoprotective effects (Deleve, 2007). Thus the targeting of 
fenestration modulation via development of appropriate pharmacological agents to 
treat pathophysiological states such as dyslipidemias in ageing (Le Couteur et al, 
2007; Le Couteur et al, 2002) and diabetes mellitus is a viable therapeutic option. 
 
VEGF activates endothelial cell division, angiogenesis and vascular permeability. It 
generates fenestrations and caveolae in a number of different endothelial cells 
including tumour (Roberts and Palade, 1997), renal (Chen et al, 2002) and 
adrenocortical (Esser et al, 1998) endothelial cells. In the liver, hepatocytes produce 
VEGF which acts on liver endothelial cells via the receptors: VEGFR1 (Flt-1) and 
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VEGFR2 (KDR/Flk-1) of which VEGFR2 is the most important (Ferrara, 2002; 
Funyu et al, 2001; LeCouter et al, 2003). In isolated liver endothelial cells, VEGF 
increases porosity about twofold, mostly through its effects on the number of 
fenestrations (Funyu et al, 2001; Yokomori et al, 2003). Conversely, transgenic 
inhibition of VEGF receptors altered the hepatic endothelium of early postnatal mice, 
including loss of endothelial lining in many sinusoids (Gerber et al, 1999) and was 
associated with defenestration and hyperlipidemia (Carpenter et al, 2005). VEGF is 
considered to be the major cytokine involved in the regulation of fenestrations (Chen 
et al, 2002). Therefore amongst the currently available fenestration modulating agent 
possibilities (Table. 1.2 and Table. 1.3), VEGF can be considered as a forerunner 
pertaining to therapeutic options to modulate fenestrations in pathophysiological 
states. 
 
In this thesis, the following major hypotheses are explored: 
 
1. Pyocyanin induces defenestration of the LSEC both in vitro and in vivo 
2. The effects of pyocyanin on the LSEC are mediated by oxidative stress  
3. Defenestration induced by old age and poloxamer 407 causes intrahepatocytic 
hypoxia and upregulation of hypoxia-related responses 
4. Defenestration of the LSEC seen in old age can be exacerbated by diabetes 
mellitus and prevented or ameliorated by caloric restriction commencing early in 
life 
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Chapter 2 
 
Liver sinusoidal endothelial cells and 
acute hepatic injury induced by 
Pseudomonas aeruginosa pyocyanin 
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2. Liver sinusoidal endothelial cells and acute hepatic injury 
induced by Pseudomonas aeruginosa pyocyanin 
 
2.1. Introduction 
 
Pseudomonas aeruginosa is an increasingly important cause of sepsis and death in 
organ transplant recipients, particularly those receiving liver transplants (Aduen et al, 
2005; Singh et al, 2004; Wagener and Yu, 1992). P. aeruginosa has a special affinity 
for tissue vasculature, typically surrounding blood vessels circumferentially 
(perivascular cuffing) during infection (Schaber et al, 2007; Soave et al, 1978) or 
congregating in postcapillary venules (Fetzer et al, 1967). P. aeruginosa induces 
apoptosis in the endothelial cell line, ECV304 (Takahashi et al, 1990; Valente et al, 
2000). P. aeruginosa produces a number of virulence factors including pyocyanin, a 
phenazine dye with broad range of activities including: redox activity (Britigan et al, 
1997; Hassan and Fridovich, 1980), immunomodulation (Muhlradt et al, 1986; Muller 
et al, 1989), pro-inflammatory effects (Lau et al, 2004), ROS-generation (Muller, 
2002), succinic dehydrogenase enzyme-inactivation (Harman and Macbrinn, 1963), 
cytotoxicity (Britigan et al, 1997; Lau et al, 2004), pro-apoptotic effects (Usher et al, 
2002), and induction of senescence (Muller, 2006).  
 
There are several reasons to suspect that pyocyanin might have important effects on 
the LSEC. Pyocyanin has been shown to induce oxidative stress and morphological 
changes in endothelial cells (Britigan et al, 1992). Within the liver, the sinusoidal 
endothelial cell (LSEC) is very sensitive to both oxidative stress (Cogger et al, 2001) 
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and the effects of bacterial lipopolysaccharide (LPS) (Dobbs et al, 1994; Seto et al, 
1998). However the effects of pyocyanin have not been described. LSECs are 
perforated with fenestrations, pores with diameters ranging from 30 to 300 nm, that 
facilitate the transfer of lipoproteins, particularly triglyceride-rich chylomicron 
remnants, between blood and hepatocytes (Fraser et al, 1995). Given the role of the 
LSEC in liver allograft rejection (Sumitran-Holgersson et al, 2004) and 
hyperlipidemia (Fraser et al, 1995; Le Couteur et al, 2005), changes in the LSEC 
induced by pyocyanin may have significant clinical implications. Therefore, the 
effects of pseudomonal pyocyanin on the structure of isolated LSECs were 
investigated and whether such effects are mediated by oxidative stress. 
 
Another possible mechanism for possible LSEC changes is the alteration of caveolin-
1 expression. LPS, which induces defenestration in LSECs (Dobbs et al, 1994), also 
induces the overexpression of caveolin-1 (Kamoun et al, 2006), which is a key 
component of fenestrations (Ogi et al, 2003). Similarly, pyocyanin could possibly 
influence fenestrations through its interactions with proteins such as F-actin or 
caveolin-1 that maintain fenestrations (Braet et al, 2003; Ogi et al, 2003).  
 
The LSEC has a key role in the maintenance of liver function and its viability 
following ischemia-reperfusion and transplantation. The rejection of donor livers is 
associated with demonstrable LSEC antibodies (Sumitran-Holgersson et al, 2004). 
LSEC apoptosis correlates with preservation-perfusion related dysfunction of donor 
rat livers (Zhu et al, 2006) and LSEC apoptosis without concomitant hepatocellular 
injury occurs in preservation injury during liver transplantation (Gao et al, 1998). Rat 
livers subjected to cold ischemia-warm reperfusion injury undergo LSEC alterations 
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without accompanying hepatocellular changes (Huet et al, 2004). LSEC responses to 
ischemia-reperfusion injury in donor rat livers influence the outcome of 
transplantation (Shimizu et al, 2001; Sun et al, 2001). For such reasons, changes 
induced in the LSEC are likely to have significant clinical outcomes in terms of liver 
transplantation. 
 
Therefore it was postulated that the effects of pyocyanin on the LSEC are a key 
component of the toxicity of pseudomonal sepsis. Better knowledge of the 
pathogenesis of the changes in LSECs induced by pyocyanin may partially explain the 
mechanisms of liver allograft rejection (Sumitran-Holgersson et al, 2004) and 
hyperlipidemia of sepsis (Fraser et al, 1995; Harris et al, 2000; Spitzer et al, 1988). 
Since P. aeruginosa is a major cause of sepsis and death following liver 
transplantation and the LSEC is critical for graft survival, the effects of P. aeruginosa 
pyocyanin on LSECs were investigated using electron microscopy, 
immunohistochemistry and biochemistry.  
 
 
 68 
2.2. Materials and methods 
 
2.2.1. Synthesis of pyocyanin 
 
Pyocyanin was chemically synthesized by the photolysis of phenazine methosulfate 
(Knight et al, 1979) and purified (Muller and Sorrell, 1992) as described earlier. 
Briefly, phenazine methosulfate (P-9625-5g, Sigma-Aldrich Pt Ltd, Sydney, 
Australia) was made up in 0.01 M tris-HCl buffer (pH 7.4) in a round-bottomed Pyrex 
flask and exposed to fluorescent tube light (Phillips TLD 18 W/54) for 2.5 hours. The 
resulting solution was extracted with chloroform and vacuum dried to a powdery 
residue. The residue was dissolved in chloroform and acidified with an equal volume 
of 0.1 M HCl. The red acidic form of pyocyanin was converted into the blue form 
using 0.5 M NaOH. This blue form of pyocyanin, now in the aqueous phase was 
extracted with chloroform and this cycle repeated 3 times. At the end of the last cycle, 
the blue form of pyocyanin was extracted with chloroform; vacuum dried, and hexane 
washed. The residue was dissolved in a small quantity of chloroform and sufficient 
hexane added to precipitate the pyocyanin. This pyocyanin was trapped using a type 
EH 0.5 µm filter, reconstituted in chloroform and purified by thin-layer 
chromatography (HPTLC Pre-coated Silica Gel 60 Plates; Merck Ltd) using an 
equimolar chloroform methanol mixture solvent. The purity of pyocyanin was 
ascertained and it’s concentration quantitated by utilizing its known absorption 
spectrum and extinction coefficient values as elucidated earlier (Watson et al, 1986). 
The pyocyanin thus purified was stored in methanol at -70°C and protected from light 
owing to its photosensitivity. Before use, the methanol solvent was completely 
removed in a stream of nitrogen gas to leave behind a dried pyocyanin residue. When 
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completely dry, the pyocyanin was reconstituted in tissue culture medium or saline 
and immediately used. 
 
2.2.2. Animal protocols, LSEC isolation and pyocyanin treatment and 
enzyme pre-treatment 
 
Animal studies were approved by the Sydney Southwest Area Health Service Animal 
Welfare Committee. All rats were specific pathogen free males obtained from the 
Animal Research Centre (Perth, Australia). Each rat used was anesthetized with 
ketamine and xylazine (50 and 5 mg/kg, respectively, Troy Laboratories, Smithfield, 
Australia) by intraperitoneal injection.  
 
LSECs were harvested from livers of Sprague-Dawley rats (aged 2-3 months, 250-350 
g) according to methodology described previously (Cogger et al, 2004). Briefly, livers 
were perfused with 0.05 % collagenase and LSECs centrifuged with a 2-step Percoll 
gradient. After centrifugation and selective adherence to remove Kupffer cells, LSECs 
were suspended in RPMI-1640 medium (0.02 % L-glutamine, 2% fetal bovine serum, 
100 U/mL penicillin, 100 µg/mL streptomycin). The resulting cells were plated onto 
collagen-coated Thermanox cover slips (Nalge Nunc Int, Rochester, NY) at a density 
of 1.60 × 106 /ml at 37°C in RPMI-1640 media with 2% FCS (GIBCO, Invitrogen 
Pty Limited, Australia) and antibiotics (100 U/ml penicillin, 100 g/ml streptomycin). 
A series of dose-response experiments in triplicate were performed to assess the 
effects of pyocyanin at the following concentrations: 0, 10, 20, 50 and 100 µM. These 
concentrations were chosen because pyocyanin has been detected in vivo at 
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concentrations of 1-130 µM (Wilson et al, 1988). For the experiments involving anti-
oxidant enzymes, pyocyanin was added to LSECs at a concentration of 10 µM then 
incubated at 37°C for 1 hour prior to sampling. In selected experiments, immediately 
before adding pyocyanin, superoxide dismutase (SOD) (from bovine erythrocytes; 
Sigma-Aldrich, St. Louis, MO, USA; S-2515; at a concentration of 30 U/mL) and/or 
catalase (from bovine liver; Sigma-Aldrich, St. Louis, MO, USA; C-40; at a 
concentration of 3000 U/mL) were added. For ten to thirty scanning electron 
microscopic fields to be studies for each treatment group, experiments were 
performed in triplicate or duplicate. 
 
The in vivo experiments were performed in male Fisher F344 rats (aged 2-3 months, 
approximately 200 g). A midline laparotomy incision was made in anesthetised 
animals and saline (n = 5) or pyocyanin (n = 7) was injected into the portal vein. 
Pyocyanin, when injected portally, was calculated to give a final systemic 
concentration of 11.9 µM. Total blood volume was calculated for each rat using the 
following formula (Lee and Blaufox, 1985), Blood Volume (ml) = 0.06 × BodyWeight 
(g) + 0.77. The laparotomy was closed and respiratory rate monitored. After 30 
minutes, the incision was re-opened. Blood was collected from the inferior vena cava 
for biochemical analysis, and the liver was removed and processed for scanning 
electron microscopy and immunohistochemistry as described previously (Cogger et 
al, 2006; Cogger et al, 2004). Two lobes were snap-frozen in liquid nitrogen for 
biochemical analyses.  
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2.2.3. Electron microscopy  
 
Scanning electron microscopy of LSECs and liver tissue blocks was performed as 
described previously (Cogger et al, 2006; Cogger et al, 2004) with a Jeol JSM-
6380LV scanning electron microscope (Jeol, Akishima-Shi, Japan). All scanning 
electron micrographs were analysed using ImageJ (http://rsb.info.nih.gov/ij/) to 
determine endothelial porosity, average fenestration diameter, fenestration density and 
the presence of gaps. Endothelial porosity is the area of the endothelial surface 
covered with fenestrations is calculated by dividing the sum total of the individual 
area of each fenestration in a given field divided by the total area of that particular 
field examined. Endothelial porosity is expressed as a percentage and is dependent on 
2 parameters, the fenestration diameter and the fenestration density. Fenestration 
density is the number of fenestrations in a specific field measured. Fenestration 
density is expressed as the number of fenestrations/ µm2. Fenestration diameter is 
expressed in nanometers (nm).  
 
For electron microscopic processing of isolated LSECs, LSECs were fixed with 3 % 
glutaraldehyde in 0.1 M Na-Cacodylate buffer with 0.1 M sucrose at room 
temperature for 1 hour, post-fixed with filtered 1% tannic acid in 0.15 mol/L Na-
cacodylate at pH 7.4 for 1 hour and post- fixed yet again with 1% osmium tetroxide in 
0.1 mol/L Na-cacodylate at pH 7.4 for 1 hour. They were dehydrated in a graded 
ethanol series, dried with hexamethyldisilazane, and sputter coated with 10 nm of 
gold. The samples were examined with a Jeol JSM-6380LV scanning electron 
microscope (Jeol, Akishima-Shi, Japan). For analysis of isolated LSECs, three 
representative micrographs from each of four cellular fields per cover-slip were taken 
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at 15000× magnification. The number of fenestrations analyzed for each treatment 
were: control 1860, pyocyanin 10 µM 1084, pyocyanin 10 µM + SOD 1521, 
pyocyanin 10 µM + catalase 1079, and pyocyanin 10 µM + SOD + catalase 2858. 
 
Processing of liver tissue blocks for scanning electron microscopy was performed as 
follows. Liver tissue blocks measuring approximately 1 mm3 each were fixed with 3% 
glutaraldehyde and 2.5 % paraformaldehyde in 0.1 M Na-cacodylate buffer with 0.1 
M sucrose and 2 mmol/ L CaCl2 and postfixed with 1% osmium tetroxide in 0.1 M 
Na-cacodylate at pH 7.4. They were dehydrated using a graded ethanol series, dried 
with hexamethyldisilazane, and sputter coated with 20 nm of platinum. A total of 12 
representative fields from at least 3 liver blocks per animal were photographed at 
25000× magnification.  
 
Transmission electron microscopy of liver tissue sections was performed as described 
previously (Cogger et al, 2004). Briefly, two technically eligible blocks per liver were 
examined. Sections from each block were chosen at random for ultrastructural 
measurement. Twenty representative micrographs per animal were taken at 19000× 
and 10 at 4600× with a Philips CM10 Transmission Electron Microscope fitted with a 
Megaview III camera and Analysis software (Olympus). The 19000× micrographs 
were analysed with Image J to measure endothelial thickness, gap frequency, and 
fenestration frequency. Fenestrations were defined as pores < 300 nm in diameter and 
gaps were defined as pores > 300 nm. The 4600× micrographs were analysed with 
Image J to measure collagen bundle, Kupffer cell activation and hepatocyte 
mitochondria.  
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2.2.4. Light microscopy and immunohistochemistry 
 
Liver specimens were fixed in 4% paraformaldehyde buffered saline and embedded in 
paraffin for light microscopy and immunohistochemistry. 4 µm sections were stained 
with haematoxylin and eosin for light microscopy. Immunohistochemistry was used 
to detect the differences in staining intensity, distribution and pattern of caveolin-1, 
which is present on the plasma membrane of LSEC fenestrations (Ogi et al, 2003); 3-
nitrotyrosine, which marks tyrosine nitration occurring during oxidative stress; and 
malondialdehyde, which indicates lipid peroxidation occurring during oxidative 
stress. Immunohistochemical staining was performed using an indirect polymer 
immunoperoxidase method. Four µm sections of fixed liver tissue were deparaffinized 
in xylene (3×3 min) and taken to absolute ethanol (3×2 min). Endogenous peroxidase 
was blocked by incubating slides in 3% H2O2 in absolute methanol for 10 min at room 
temperature. After hydrating the sections, the slides utilized for nitrotyrosine and 
caveolin-1 immunohistochemistry were heated at 125°C for 4 min in a Decloaking 
Chamber (Biocare Medical) with epitope retrieval buffer and then cooled. This was 
followed by incubation with goat serum for 20 min. Without washing, the primary 
antibodies were applied and incubated overnight. The primary antibodies used were 
rabbit anti-human caveolin-1 antibody (N-20, Cruz Biotechnology, Santa Cruz, CA, 
USA), mouse monoclonal anti-nitrotyrosine antibody (ab7048, Abcam), and rabbit 
polyclonal anti-malondialdehyde antibody (ab6463, Abcam). The epitope retrieval 
buffers used were citrate buffer (0.01 M, pH 6.0) for caveolin-1 and tris buffer (0.05 
M Tris-EDTA, pH 8.0) for 3-nitrotyrosine immunohistochemistry. No pre-treatment 
was needed for tissues for malondialdehyde immunohistochemistry. During the 
immunostaining all slides were washed in washing buffer (0.001 M Tris, pH 7.6) 
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containing Tween 20. After the primary incubation, the secondary antibody, affinity 
purified goat anti-mouse or anti-rabbit immunoglobulin linked polymeric horseradish 
peroxidase (AP340P-50ML/ AP342P-50ML, Chemicon International, Inc. Australia 
Pty Ltd.) was applied for 30 min. After buffer wash, the sections were treated with 
diaminobenzidine (DAB) chromogenic substrate solution for 5 min and slides were 
washed in water. The slides were then immersed in 1% aqueous CuSO4 solution for 
further intensification of staining and counterstained with haematoxylin, dehydrated 
and mounted. The slides were graded consensually by three blinded observers 
according to staining distribution (periportal, zone 2, pericentral) and intensity of 
staining (0, +, ++, +++), and semi-quantitatively assessed. 
 
2.2.5. ATP assay 
 
ATP was measured by the luciferin-luciferase method with a luminometer as per the 
manufacturer's instructions (G7570, CellTiter-Glo™ Luminescent Cell Viability Assay 
kit, Promega, Madison, WI, USA). The luciferase enzyme requires ATP in order to 
generate light. As active cells produce ATP, after an equal volume of CellTiter-Glo™ 
reagent is added to the LSECs, luminescence is measured. The light signal produced 
is proportional to the amount of ATP present. The final ATP concentrations were 
calculated from a calibration curve constructed at the same time by means of standard 
ATP dissolved in the given buffer. Results were normalized to each well containing 
LSECs at density of 1.60 × 106 /ml. 
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2.2.6. Glutathione assay and blood biochemistry 
 
Glutathione levels were assessed in order to determine the existence or absence of 
oxidative stress on pyocyanin treated liver specimens. Liver samples were 
homogenised in ice-cold 10 % 5-sulfosalicylic acid. Samples were centrifuged and 
supernatants removed for analysis. Total glutathione (GSH + GSSG) and glutathione 
disulfide (GSSG) levels were assayed according to the recycling method of Griffith 
(Griffith, 1980). GSSG analysis entailed removal of GSH by addition of 2 µl of 2-
vinylpyridine per 100 µl of supernatant prior to the recycling reaction. 
 
Protein quantitation, blood biochemistry and liver function tests were done by the 
Biochemistry Department, Diagnostic Pathology Unit, Concord RG Hospital, using 
the automated Roche Diagnostics Modular Analytics Serum Work Area (F.Hoffmann-
La Roche Ltd). Briefly, the principles utilized in these assays are enclosed in brackets 
as follows: Total Protein (Biuret/ Endpoint with Blank), Albumin (BCG-Citrate 
buffer), ALT and AST (IFCC Modified), ALP (AMP Buffer- IFCC), LDH (IFCC 
Modified), Creatinine (Alkaline Picrate- Rate- Blank, Compensate), CK (IFCC/ 
Imidazole Buffer), Na+/K+/Cl- (Iron Specific Electrode- Indirect), HCO3- (Enymatic), 
and Ca++ (Cresol.Complex- No Dialysis). 
 
2.2.7. Western Blot analysis for pyocyanin interaction with caveolin-1  
 
To determine whether pyocyanin irreversibly binds to caveolin-1 and alters protein 
size, caveolin-1 electromobility was examined using Western Blot. Twenty 
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micrograms of cell lysate from SK-HEP-1 cells, an immortal endothelial cell-line 
(Heffelfinger et al, 1992), treated with pyocyanin; and controls were separated by 
SDS-PAGE. Lanes were run with 100 µM pyocyanin or 2 µM pyocyanin in the 
presence of lysate; or with 100 µM pyocyanin alone. Lysate, when loaded, was 
always 20 µg/ well. After transfer onto nitrocellulose membrane (Amersham 
Biosciences, Australia) the blot was blocked, incubated with primary antibodies to 
caveolin-1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), washed and incubated 
with a rabbit anti-goat IgG secondary antibody conjugated to horseradish peroxidase 
(Amersham Biosciences, Australia). Proteins were visualized using 
chemiluminescence. 
 
2.2.8. Statistical analysis 
 
Statistical analysis was performed using SigmaStat Statistics Software (SPSS Inc, 
Chicago, IL). Data are presented as the mean ± standard error of the mean. For 
isolated LSEC morphometry statistical significance levels (P < 0.05) were determined 
by one-way analysis of variance (ANOVA) with Student-Newman-Keuls method for 
post hoc pairwise multiple comparisons. For fenestration morphometry of intact 
sinusoids in the in vivo liver studies, the Mann–Whitney test were used to compare 
groups and considered significant when P < 0.05.  
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2.3 Results 
 
2.3.1. Effect of pyocyanin on porosity of isolated LSECs 
 
Treatment of LSECs with pyocyanin concentrations ranging from 0 to100 µM 
induced a dose-dependent decrease in LSEC porosity (Fig. 2.1) as measured by 
scanning electron micrograph morphometry.  
 
Figure 2.1. Pyocyanin dose and porosity of LSECs 
Porosity (%) of isolated LSECs decreased as concentration of pyocyanin increased 
from 0 to100 µM. 
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2.3.2. Effect of pyocyanin on porosity and fenestrations of isolated LSECs 
 
Treatment with pyocyanin (10 µM) was associated with a significant reduction in 
LSEC porosity from 3.3 ± 1.8 % to 1.2 ± 1.0 % (P < 0.001) with a loss of sieve plate 
organization (Fig. 2.2). This was prevented by the addition of catalase, but superoxide 
dismutase did not have any statistically significant effect (Fig. 2.3). The effects of 
pyocyanin appeared to be mediated by changes in the frequency of the fenestrations. 
Catalase appeared to improve porosity mostly by its effects on the diameter of the 
fenestrations (Fig. 2.2). 
 
2.3.3. Effect of pyocyanin on morphology of isolated LSECs 
 
All changes in cell morphology were dose-dependent (Table. 2.1). Cell membrane 
blebbing, cytoplasmic retraction and cell membrane retraction were extensive at 50 
µM, occasionally present at 10 and 20 µM but not seen at 1 and 5 µM. 
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Figure 2.2. Scanning electron microscopy of control-, pyocyanin and anti-oxidant 
enzyme-treated rat LSECs 
 
Scanning electron microscopy (Magnification 15000 ×) of isolated rat LSECs under 
control incubation conditions (A); after treatment with 10 µM pyocyanin (B); 
pyocyanin and superoxide dismutase (C); and pyocyanin and catalase (D). 
Fenestrations (→) are grouped into sieve plates in A and D. 
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Figure 2.3. Quantification of the porosity, frequency and diameter of fenestrations in 
the LSECs 
There was a reduction in fenestrations after treatment with 10 µM pyocyanin, which 
was reversed by catalase but not superoxide dismutase (* P < 0.05 compared to 
control). 
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Table 2.1. Pyocyanin dose and LSEC morphology 
 
Pyocyanin Concentration (µM)  
0 1 5 10 20 50 100 
Sieve plate obliteration - - - + + +++ - 
LSEC membrane retraction - - - + + +++ - 
Cytoplasmic contraction  - - + + +++ - 
Perinuclear plasma 
membrane blebbing 
- - - - - ++ - 
Cellular disintegration - - - - - + ++ 
 
Cell membrane blebbing, cytoplasmic retraction and cell membrane retraction were 
extensive at 50 µM, occasionally present at 10 and 20 µM but not seen at 1 and 5 µM. 
 
2.3.4. Effects of pyocyanin on ATP content of isolated LSECs 
 
ATP decreases in several cellular systems have been reported with pyocyanin 
treatment. These changes were also evident in a one-off experiment. Antioxidant 
enzymes (SOD and catalase) seemed to have a minimum ameliorating effect on 
pyocyanin-induced ATP decrease (Fig. 2.4). 
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Figure 2.4. Confirmation of cellular ATP fluctuations with pyocyanin treatment 
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ATP decreases were also evident in a one-off experiment not equilibrated with 
protein. SOD and catalase seemed to have a minimum ameliorating effect on 
pyocyanin-induced ATP decrease. 
    
2.3.5. Scanning electron microscopy of liver sinusoids  
 
Scanning electron micrograph analysis of liver sinusoids (Fig. 2.5A, 2.5B) revealed a 
decrease in porosity of liver sinusoids with pyocyanin treatment, with significant 
contributions from both fenestration diameter and fenestration frequency (number of 
fenestrations per square µm) (Table. 2.2). Pyocyanin treatment was associated with 
smaller fenestration diameters than those seen in control liver sinusoids (Fig. 2.5C). 
The number of gaps (diameter > 300 nm) was slightly raised with pyocyanin 
treatment, although statistically insignificant (Fig. 2.5C). 
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2.3.6. Transmission electron microscopy of liver sinusoids and the space of 
Disse  
 
Transmission electron micrograph analysis revealed normal hepatocyte architecture in 
both control and pyocyanin-treatment groups (Fig. 2.6). The hepatocellular nuclei, 
mitochondria and endoplasmic reticulum were well-preserved and had normal 
morphology. Pyocyanin treatment was associated with a statistically significant 
decrease in endothelial thickness from 175.8 ± 5.8 to 156.5 ± 4.0 nm (Fig. 2.6C, 2.6D, 
Table 2.2). No changes in hepatocellular mitochondrial count, collagen bundle count, 
and Kupffer cell count were observable (data not shown). 
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Figure 2.5. Scanning electron microscopy of liver sinusoids from control and 
pyocyanin-treated rats 
The fenestrations of the control liver sinusoid (A) are larger in diameter and higher in 
frequency (number of fenestrations per square µm) than those of the Pyocyanin 
treated liver (B). The arrow-head indicates a single fenestration and the full arrow, a 
sieve-plate circumscribing many fenestrations. Original magnification 25000x, scale 
bar = 1 µm. C is a histogram of fenestration diameters measured on scanning electron 
micrographs, showing a lower proportion of smaller fenestrations in pyocyanin 
treated liver endothelium than in control livers. There was a non-significant trend 
towards an increased number of gaps (> 300 nm) with pyocyanin treatment.  
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Figure 2.6. Transmission electron microscopy of livers from control and pyocyanin-
treated rats 
Organelle size and number were unaffected by pyocyanin treatment with normal 
morphology of mitochondria (M) observed in control and pyocyanin treated rats: A 
Control liver sinusoid, B Pyocyanin treated liver sinusoid. S; sinusoidal lumen, scale 
bar = 2 µm, original magnification 4600x. At original magnification 19000x, a 
decrease in the thickness of the endothelium (E) was seen in the pyocyanin treatment 
group. The space of Disse (D), hepatocytes (H) and hepatocellular endoplasmic 
reticulum (ER) appeared normal in both groups: C Control liver sinusoid, D 
Pyocyanin treated liver sinusoid. F; fenestrations, scale bar = 1 µm. 
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Table 2.2. Electron micrograph morphometry of the liver endothelium and 
peri-sinusoidal hepatocytes from rat livers with and without pyocyanin 
treatment in vivo 
 
 
 No 
Treatment 
(n= 5) 
Pyocyanin 
Treatment 
(n= 7) 
P Value 
SCANNING ELECTRON MICROSCOPY 
Porosity % 3.4 ± 0.2 1.3 ± 0.1 < 0.001 
No. of Fenestrations/ µm2 5.5 ± 0.3 2.4 ± 0.1 < 0.001 
Fenestration Diameter (nm) 80.4 ± 0.6 71.0 ± 0.8 < 0.001 
TRANSMISSION ELECTRON MICROSCOPY 
Endothelial Thickness (nm) 175.8 ± 5.8 156.5 ± 4.0 < 0.01 
 
 
 
With pyocyanin treatment, scanning electron micrograph analysis revealed a decrease 
in porosity, fenestration diameter and fenestration frequency of liver sinusoids. With 
pyocyanin treatment, transmission electron micrograph analysis revealed a decrease in 
endothelial thickness. 
 
2.3.7. Light microscopy and immunohistochemistry of livers 
 
Light microscopy (Fig. 2.7A, 2.7B), 3-nitrotyrosine immunohistochemistry (Fig. 
2.7C, 2.7D) and malondialdehyde immunohistochemistry (Fig. 2.7E, 2.7F) of livers 
revealed no observable changes with pyocyanin treatment. 
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2.3.8. Investigation of relationship of caveolin-1 to pyocyanin-induced 
endothelial changes 
 
Caveolin-1 immunohistochemistry (Fig. 2.7G, 2.7H) of livers revealed no observable 
changes with pyocyanin treatment. During Western Blot analysis for caveolin-1 (Fig. 
2.8), pyocyanin treatment of SK-HEP-1 cells did not alter caveolin-1 mobility.  
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Figure 2.7. Light microscopy and immunohistochemistry of livers from control and 
pyocyanin groups 
Light microscopy of liver sections stained with eosin and haematoxylin staining A 
Control liver, B Pyocyanin treated liver), malondialdehyde immunohistochemistry (C 
Control liver, D Pyocyanin treated liver), 3-nitrotyrosine immunohistochemistry (E 
Control liver, F Pyocyanin treated liver) and caveolin-1 immunohistochemistry (G 
Control liver, H Pyocyanin treated liver) revealed no changes across the hepatic 
lobule with pyocyanin treatment. Immunohistochemical stains appear brown, original 
magnification 100x. 
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Figure 2.8. Western blot analysis for caveolin-1  
SDS page gel run with 20 µl of SK-HEP-1 cells-lysate with 2 µM pyocyanin (Lane 
A), 100 µM pyocyanin (Lane B) or no pyocyanin (Lane D & E); or with 100 µM 
(Lane C) pyocyanin alone and stained for caveolin-1. Lysate, when loaded, was 
always 20 µg/ well (Lane A, B, D & E). Band migration was unaltered for SK-HEP-1 
cell lysate with and without pyocyanin treatment. 
 
 
2.3.9. Blood glutathione and biochemistry 
 
The GSSG to GSSG + GSH ratio was 60 ± 15 % of that seen in controls and was 
statistically insignificant. Serum biochemistry including liver function tests (total 
protein, albumin, ALT, AST, ALP) and analysis of markers of cytolysis (LDH, CK, 
creatinine, K+) showed no significant change with pyocyanin treatment (Table 2.3). 
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Table 2.3. Liver function tests and markers of cytolysis with and without 
 in vivo pyocyanin 
 
 
No Treatment 
(n= 5) 
Pyocyanin 
 (n= 7) 
ELECTROLYTES 
Na+ (mmol/ L) 134.5 ± 0.6 134.6 ± 0.4 
Ca++ (mmol/ L) 2.5 ± 0.0 2.7 ± 0.1 
Cl- (mmol/ L) 96.5 ± 0.6 95.6 ± 0.5 
HCO3- (mmol/ L) 28.5 ± 1.0 26 ± 0.9 
LIVER FUNCTION TESTS 
ALP (U/L) 186.6 ± 16.7 174.2 ± 12.2 
ALT(U/L) 69.0 ± 13.7 71.5 ± 8.4 
AST(U/L) 90.6 ± 14.3 120.2 ± 33.4 
Protein (g/L) 52.0 ± 1.2 54.4 ± 1.0 
Albumin (g/L) 33.2 ± 0.8 34.4 ± 0.8 
MARKERS OF CYTOLYSIS 
LDH (U/L) 264.3 ± 24.8 747 ± 227.8 
CK Total (U/L) 832.4 ± 128.0 1642.7 ± 348.2 
Creatinine (mmol/ L) 28.4 ± 1.0 30.2 ± 1.9 
K+ (mmol/ L) 6.4 ± 0.2 5.9 ± 0.2 
 
Serum electrolytes, liver function tests and markers of cytolysis showed no 
statistically significant changes with pyocyanin treatment.  
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2.4. Discussion 
 
This study demonstrates that pyocyanin treatment over a wide range of concentrations 
is associated with a substantial loss of LSEC porosity. Pyocyanin also induces 
significant acute changes in the in vivo liver sinusoidal endothelium without evidence 
that these changes are mediated by reactive oxygen and nitrogen species. These LSEC 
changes were not accompanied by evidence of structural or biochemical 
hepatocellular changes. 
 
Many toxins have been shown to induce LSEC injury. In particular, oxidative stress 
has been shown to have dramatic effects on the morphology of the LSEC. We found 
that H2O2 (0.7 mM) delivered via the portal vein in the perfused liver had effects that 
were largely confined to the perisinusoidal areas (Cogger et al, 2001) and that tert-
butyl hydroperoxide injected into the portal vein in vivo and in isolated LSECs caused 
disruption of the liver sieve plates (Cogger et al, 2004). Regards pyocyanin, Britigan 
and coworkers used spin trapping to show that pyocyanin induced oxidative injury via 
the hydroxyl free radical in pulmonary artery endothelial cells (Britigan et al, 1992; 
Miller et al, 1996).  
 
Pyocyanin-induced H2O2 production by human umbilical vein endothelial cells with 
marked depletion of intracellular glutathione, and these changes were preventable by 
catalase (Muller, 2002). In this study exploring the effects of pyocyanin on isolated 
LSECs, catalase which inactivates hydrogen peroxide to water, prevented pyocyanin-
induced morphological changes in the LSECs, specifically defenestration. In this 
study in intact livers in vivo, portally injected pyocyanin (blood concentration of 11.9 
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µM for 30 min) induced a dose-dependent loss of porosity in isolated LSECs. 
Furthermore, portally injected pyocyanin in vivo led to a significant reduction in 
porosity of the endothelium showing that this effect is seen both in vivo and in vitro. 
In addition, a decrease in endothelial thickness with pyocyanin was noted, a change 
that has not been reported with any other toxic injury to the LSEC. 
 
It is important to note that the ultramicroscopic LSEC changes were present without 
any morphological hepatocellular alterations including mitochondrial morphology and 
frequency or any other signs of hepatocyte injury or oxidative stress. This indicates 
that the LSEC is initial site of injury induced by pyocyanin, and indeed may even 
have a role in protecting hepatocytes from endo- and xenobiotics. There were no 
changes in malondialdehyde and 3-nitrotyrosine immunohistochemistry. A decrease 
in 3-nitrotyrosine immunohistochemical staining was expected because of  previous 
reports incriminating pyocyanin in the inhibition of nitric oxide production (Warren et 
al, 1990) via guanylyl cyclase inhibition (Hussain et al, 1997), but no differences 
accruing with pyocyanin treatment were observed in this study. Likewise, although an 
increase in malondialdehyde immunohistochemistry was expected owing to the 
possibility of increased membrane-lipid peroxidation via H2O2 production with 
pyocyanin treatment (Muller, 2002), no differences were oberved. This is in 
contradistinction to the studies in isolated LSECs where an increase in markers of 
oxidative stress was found. It is plausible that in vivo, hepatocyte-derived antioxidants 
prevented any overall changes in markers of oxidative stress but not sufficient to 
prevent defenestration of the LSEC. Alternatively, it is possible that pyocyanin 
induces defenestration through mechanisms independent of oxidative stress.  
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To explore this possibility, caveolin-1, a membrane protein involved in the 
maintenance of fenestrations, was studied (Braet et al, 2003; Ogi et al, 2003). It has 
been demonstrated that LSEC defenestration, which occurs in models of pathological 
liver states such as cirrhosis (Nopanitaya et al, 1976) and type 1 diabetic liver 
(Jamieson et al, 2007), is accompanied by caveolin-1 overexpression. Similarly, LPS 
which induces defenestration in LSECs (Dobbs et al, 1994), also induces the 
overexpression of caveolin-1 (Kamoun et al, 2006) (Table 2.4). However, there were 
no caveolin-1 immunohistochemical changes with the liver endothelial defenestration 
induced by pyocyanin. The possibility of pyocyanin binding to caveolin-1 or altering 
the properties of caveolin-1 was also investigated. Again, there was no alteration in 
caveolin-1 using an immunoblot method. These results exclude the possibility that 
pyocyanin induces defenestration via any major effects on caveolin-1. Therefore it is 
possible that pyocyanin induces defenestration through mechanisms independent of 
oxidative stress or interaction with caveolin-1. As pyocyanin has been shown to 
influence the expression and secretion of numerous cytokines (Leidal et al, 2001; 
Muhlradt et al, 1986), further investigations into the expression and activity of these 
cytokines may serve to partly or fully unravel the appropriate mechanism (Table 2.4). 
 
The observation that pyocyanin influences endothelial morphology may have 
significant clinical implications. LSECs are important in tolerance induction in liver 
transplantation and rejection of donor livers correlates closely with the presence of 
LSEC antibodies (Sumitran-Holgersson et al, 2004). Furthermore, LSEC responses to 
ischemia-reperfusion injury in the donor organ influences outcome of liver 
transplantation (Shimizu et al, 2001; Sun et al, 2001). Thus damage to the LSEC 
induced by pyocyanin could impact graft outcome and prognosis following 
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pseudomonal sepsis. It has also been reported that hyperlipidemia is an important 
response to sepsis. The mechanism for sepsis-associated hyperlipidemia is 
multifactorial, but impaired catabolism of lipoproteins is a contributory factor (Harris 
et al, 2000; Spitzer et al, 1988). LSECs, which are perforated with fenestrations that 
facilitate the transfer of lipoproteins between blood and hepatocytes, have an 
increasingly recognized role in hyperlipidemia (Fraser et al, 1995). Conditions 
associated with reduced numbers of fenestrations such as ageing (Hilmer et al, 2005) 
and treatment with the surfactant poloxamer 407 (Cogger et al, 2006) are associated 
with impaired lipoprotein uptake by the liver and hypertriglyceridemia. The results 
here with pyocyanin support the concept that hyperlipidemia associated with sepsis 
might in part be a result of LSEC defenestration. Pseudomonal sepsis may cause the 
release of toxins like pyocyanin and LPS which may lead to endothelial changes 
including loss of LSEC porosity, subsequently excluding lipoproteins from the liver, 
leading to lipoprotein retention in the peripheral vasculature. This mechanism may 
account for sepsis-related hyperlipidemia (Fig. 2.9). In the current study, the 30 min 
of pyocyanin exposure would not have been sufficient to cause profound changes in 
blood lipoprotein levels.  
 
In conclusion, the P. aeruginosa toxin, pyocyanin caused loss of fenestrations over a 
range of concentrations in isolated LSECs as well as the in vivo liver endothelium. 
This has potential implications for mechanisms for liver transplantation and for 
hyperlipidemia associated with sepsis. The ultrastructural LSEC changes in the 
absence of hepatocellular injury indicate that the LSEC is a prime target for 
pyocyanin and support the sentinel role of the LSEC in hepatoprotectivity. Pyocyanin-
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induced LSEC changes seen in vivo in the absence of free radical or oxidative stress 
injury points to a novel mechanism for the pathogenesis of P. aeruginosa pyocyanin.  
 
Figure 2.9. Possible pathogenetic mechanism of pseudomonal sepsis-related 
hyperlipidemia 
 
LSEC defenestration in bacterial/ pseudomonal sepsis owing to toxins like pyocyanin 
or LPS may exclude lipoproteins from the liver leading to lipoprotein retention in the 
peripheral vasculature accounting for bacterial/ pseudomonal sepsis-related 
hyperlipidemia. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.4 . Possible defenestration mechanisms of pseudomonal agents  
 
 Pseudomonal agent 
inducing defenestration 
Location of 
LSECs in study 
Possible 
mechanism 
Mechanisms 
excluded 
Citations 
1 Pyocyanin Isolated LSECs in 
vitro ROS  - 
This study 
2 Pyocyanin 
Intact in vivo liver 
sinusoids (this 
study only) 
Cytokines?  
Vasoactive 
mediators? 
ROS, 
caveolin-1 
This study, 
(Leidal et al, 
2001; Muhlradt 
et al, 1986) 
3 
LPS (E. coli LPS- 
structurally similar to 
pseudomonal LPS) 
Isolated LSECs in 
vitro and intact in 
vivo liver sinusoids 
Caveolin-1? 
Vasoactive 
mediators? 
 
(Dobbs et al, 
1994; Kamoun 
et al, 2006) 
 
 
Possible mechanisms behind pseudomonal agent-induced defenestration 
Defenestrated 
 
LSECs 
LSEC layer 
Hepatocyte 
Pseudomonal 
toxin induced 
defenestration 
Space of Disse 
 
Hyperlipidemia of sepsis 
Lipoproteins Lipoproteins 
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3. The effect of old age on liver oxygenation, sinusoidal 
fenestrations and the expression of VEGF and VEGFR2 
 
3.1 Introduction 
 
It has been well established that phase 1 hepatic drug metabolism, which involves 
oxidation, reduction or hydrolysis, is diminished in old age (Herrlinger and Klotz, 
2001; Kinirons and O'Mahony, 2004). These age-related changes could be caused by 
decreased liver perfusion (Schmucker, 2001), oxygen-diffusion barrier secondary to 
age-associated liver pseudocapillarization of the liver sinusoidal endothelial cell (Le 
Couteur et al, 2001), mitochondrial oxidative stress (Sastre et al, 2003) or 
mitochondrial dysfunction (Sastre et al, 1996). In the oxygen diffusion barrier 
hypothesis, it was proposed that the disparity between in vivo and in vitro measures of 
phase I drug metabolism in old age (Herrlinger and Klotz, 2001; Kinirons and 
O'Mahony, 2004), could reflect intrahepatocytic hypoxia because oxygen is an 
essential cofactor for cytochrome P450 enzymes (Le Couteur and McLean, 1998). 
Using 31P-nuclear magnetic-resonance studies on freeze-clamped samples, it was 
reported that aged rat livers have decreased ATP and high-energy phosphate 
metabolite pools, suggestive of hypoxia (Le Couteur et al, 2001). Others have shown 
that livers from old mice have less total ATP (Selzner et al, 2007). However, this was 
associated with diminished oxygen consumption and ATP production by isolated 
mitochondria, which is suggestive of mitochondrial dysfunction rather than hypoxia 
(Selzner et al, 2007). Apart from changes in ATP levels, it has also been reported that 
there is upregulation of several genes and proteins that respond to hypoxia in old age. 
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Using Western Blotting and RT-PCR it was shown that the hypoxia marker Hypoxia 
Inducible Factor-1α (HIF-1α) and hypoxia-responsive products such as Heme 
Oxygenase-1 (HO-1), Vascular Endothelial Growth Factor (VEGF), Erythropoietin, 
and inducible nitric oxide synthase (iNOS) were increased in aged rat liver (Kang et 
al, 2005). Age-related changes in hepatic ATP and oxygenation could be caused by 
decreased oxygen delivery to hepatocytes secondary to either reduced liver perfusion 
(Schmucker, 2001), or an oxygen-diffusion barrier secondary to age-associated 
“pseudocapillarization” of the liver sinusoidal endothelial cell (LSEC) (Le Couteur et 
al, 2001). On other hand, the reduction in ATP might also be secondary to age-related 
mitochondrial oxidative stress (Sastre et al, 2003) or mitochondrial dysfunction 
(Sastre et al, 1996). 
 
Alterations in liver oxygen and ATP will have specific implications for age-related 
changes in the LSECs. Morphological age-related changes in the hepatic sinusoid 
include endothelial thickening, defenestration, basement membrane formation and 
sporadic collagen disposition in the space of Disse, collectively called age-related 
‘pseudocapillarization’ (Le Couteur et al, 2005). Pseudocapillarization impedes 
transfer of substrates such as lipoproteins from the sinusoidal lumen to the hepatocyte 
(Hilmer et al, 2005). Although the normal hepatic sinusoidal endothelium provides an 
insignificant resistance to oxygen transfer (Kassissia et al, 1992; Le Couteur et al, 
1999), there is a significant diffusion barrier to oxygen diffusion posed by the blood 
vessels in cirrhosis (Froomes et al, 2003; McLean and Morgan, 1991) and in normal 
capillaries in other organs (Cho et al, 2001; Rose and Goresky, 1985). It was therefore 
hypothesized that age-related pseudocapillarization might also constitute an oxygen 
diffusion barrier analogous to that seen in cirrhosis (Le Couteur and McLean, 1998). 
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Age-related changes in the LSEC (‘pseudocapillarization’) have been partially 
induced by ATP depletion (Braet et al, 2003). 
 
Furthermore, age-related changes in hepatic oxygen-dependent metabolism and 
oxygenation might contribute to age-related pseudocapillarization of the LSEC. 
Depletion of ATP has been shown to induce marked defenestration of isolated LSECs 
(Braet et al, 2003). Hypoxia also induces VEGF and VEGF receptors. VEGF is a 
potent stimulus for the generation of fenestrations in isolated LSECs (Funyu et al, 
2001) and the VEGFR2 knockout mouse is defenestrated (Carpenter et al, 2005). The 
effects of old age on LSEC ATP levels and liver VEGF and VEGFR2 expression are 
not established but may have implications for the pathogenesis of ageing change in 
the hepatic sinusoid. 
 
Therefore, here it was investigated whether ageing is associated with in vivo hypoxia 
in the aged rat liver. Immunohistochemistry with pimonidazole, and ATP levels in 
isolated LSECs were used to determine the presence of hypoxia in the hepatocytes 
and LSECs, respectively. 2-Nitroimidazoles including pimonidazole have been 
reliably used as in vivo hypoxia markers in a number of systems (Arteel et al, 1998). 
Nitroimidazole-adduct formation, which is increased in regions with low oxygen 
tension, is determined by immunohistochemistry. Staining is substantially increased 
when the intracellular oxygen tension falls below 10 mm Hg (Gross et al, 1995). 
Here, pimonidazole immunohistochemistry was performed on four young (4-month 
old) and six old (2-year old) rats in an attempt to directly visualize and compare the 
distribution and intensity of hypoxic areas in young and old rat livers. The ubiquitous 
synthetic surfactant poloxamer 407 was also used to induce defenestration of the 
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LSEC in livers of young rats (Cogger et al, 2006) in order to determine whether 
structural changes in the LSEC can induce hypoxia and thus test the concept of an 
oxygen diffusion barrier. Poloxamer 407 induces defenestration of the LSEC, 
probably by coating the LSEC cell membrane (Cogger et al, 2006). Finally, the effects 
of age on the expression of VEGF and VEGFR2 were studied because these respond 
to hypoxia (Ferrara, 2004; Ferrara et al, 2003) and also because any changes in their 
expression may shed light on the pathogenesis of pseudocapillarization of the LSEC. 
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3.2  Materials and methods 
 
3.2.1. Animal protocols 
 
The studies had approval by the Sydney Southwest Area Health Service Animal 
Welfare Committee. Rats were anesthetized with Ketamine and Xylazine (50 and 5 
mg/kg respectively, Troy Laboratories, Smithfield, Australia) by intraperitoneal 
injection. Blood was collected from the inferior vena cava and the liver removed and 
processed for scanning electron microscopy and immunohistochemistry as described 
previously (Cogger et al, 2001). For the pimonidazole studies to determine the effect 
of ageing on hepatic oxygenation, specific pathogen free male Fisher F344 rats were 
obtained from the National Institute of Aging, Bethesda, Maryland, USA. Young (4 
months, 315-346 g; n = 4) and old (24 months, 322-440 g; n = 6) rats were used. 
Pimonidazole (HP1-1000, Chemicon) was administered by intraperitoneal injection at 
a dose of 120 mg/ kg body weight two hours prior to harvesting the livers. For the 
poloxamer 407 study, male Sprague-Dawley rats (3-4 months, 381-477 g) obtained 
from the Animal Research Centre (Perth, Australia) were used. In this study, 
poloxamer 407 (gifted by BASF Australia Ltd, Sydney, Australia; 1 g/ kg body 
weight, n = 5) was administered in the test rats by intraperitoneal injection 24 hours 
prior harvesting the livers.  
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3.2.2. Immunohistochemistry  
 
Immunohistochemical staining was performed using an indirect polymer 
immunoperoxidase method. Liver specimens were fixed in 4% phosphate buffered 
formalin and embedded in paraffin. Four micrometer sections were deparaffinized in 
xylene (3 × 3 min) and taken to absolute ethanol (3 × 2 min). Endogenous peroxidase 
was blocked by incubating slides in 3% H2O2 in absolute methanol for 10 min at room 
temperature. After hydrating the sections, the slides were heated at 125°C for 4 min in 
a pressure cooker (Decloaking Chamber, Biocare Medical) with epitope retrieval 
buffer and then cooled. This was followed by treatment with goat serum for 5 min. 
The primary antibody was applied and incubated overnight. The primary antibodies 
used were Hypoxyprobe Mab-1 (HP1-1000, Chemicon) for pimonidazole 
immunohistochemistry, mouse monoclonal VEGF antibody (ab1316, Abcam), and 
rabbit polyclonal VEGFR2 antibody (ab2349, Abcam). The epitope retrieval buffers 
used were citrate buffer (0.01 M, pH 6.0) for pimonidazole and VEGF 
immunohistochemistry, and Tris buffer (0.05 M Tris-EDTA, pH 8.0) for VEGFR2 
immunohistochemistry. The slides were washed in Tris wash buffer (0.01 M Tris-
EDTA, pH 7.6). Then the secondary antibody, goat anti-mouse immunoglobulin 
polymer conjugated with horseradish peroxidase (TL-060-HL, LabVision, DKSH 
Australia Pty Ltd.) was applied for 30 min. After buffer wash, the sections were 
treated with diaminobenzidine (DAB) substrate for 5 min treated with 1% CuSO4, 
counterstained with haematoxylin, dehydrated and mounted. Sixteen random 
photographs per blinded slide were taken, graded by four observers blinded to the 
identity of the slides, according to staining distribution (periportal, zone 2, pericentral) 
and intensity of staining (0, +, ++, +++). Subsequently, after reaching a consensus, the 
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resultant grading was semi-quantitatively assessed by using Chi-square analysis for 
intensity differentiation. 
 
3.2.3. Scanning electron microscopy  
 
Scanning electron microscopy was performed as described previously (Cogger et al, 
2001; Le Couteur et al, 2001; McLean et al, 2003). Briefly, liver specimen blocks 1 
mm3 each were fixed with 3 % glutaraldehyde in 0.1 M Na-Cacodylate buffer with 
0.1 M sucrose and post- fixed with 1% osmium tetroxide in 0.1 mol/L Na-cacodylate 
at pH 7.4. They were dehydrated using a graded ethanol series, dried with 
hexamethyldisilazane, and sputter coated with 15- 20 nm of platinum. These were 
examined with a Jeol JSM-6380LV scanning electron microscope (Jeol, Akishima-
Shi, Japan). A total of 12 representative fields from at-least 3 liver blocks per animal 
were photographed at 25000× magnification. Using the photographs thus obtained the 
software program ImageJ (http://rsb.info.nih.gov/ij/) was used to determine 
endothelial porosity, average fenestration diameter, and fenestration density. 
Endothelial porosity, the percentage area of the endothelial surface covered with 
fenestrations is dependent on 2 parameters, the fenestration diameter and the 
fenestration density which is the sum total of the individual area of each fenestration 
in a given field divided by the total area of the field examined, expressed as a 
percentage. 
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3.2.4. LSEC isolation 
 
The method for the isolation of LSECs has been described (Braet et al, 1994; 
Smedsrod et al, 1985). The livers of young and old male F344 rats were perfused with 
collagenase A (Sigma) and the cell suspension centrifuged at 100 × g for 5 min. The 
supernatant, containing a mixture of sinusoidal liver cells, was layered on a 2-step 
Percoll gradient (25–50%) and centrifuged for 20 min at 900 × g. The intermediate 
zone was enriched in LSECs. LSEC purity was enhanced by selective adherence of 
Kupffer cells onto untreated plastic Petri dishes for 5 min. For SEM, LSECs were 
cultivated in 24-multiwell plates on collagen coated Thermanox cover slips in serum-
free culture medium consisting of RPMI-1640 with 2 mmol/l L-glutamine, 100 U/ml 
penicillin, and 100 g/ml streptomycin.  
 
3.2.5. ATP and protein assays 
 
For the determination of cellular ATP, LSECs were plated at 0.8 × 106 cell/ml (100 
l/well) into clear bottom, opaque wall 96-well tissue culture plates and cultured for 
16 h (37oC/5% CO2) in RPMI-1640 with fetal bovine serum (5%), L-glutamine (2 
mmol/L), penicillin (100 U/mL) and streptomycin (100 g/ml). ATP was assayed using 
a CellTiter-Glo luminescent cell viability assay kit (Promega, Sydney) with an ATP 
standard curve. The luminescent signal was detected using a FluorStar Optima plate 
reader equipped with a luminescence probe. To determine cellular protein content, 
cells were washed twice with PBS to remove serum and protein quantified using the 
bicinchoninic acid protein determination kit (Sigma, Sydney). 
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3.2.6. Statistics 
 
SigmaStat Statistics Software (SPSS Inc, Chicago, IL) was used for statistical 
analysis.  Data are presented as mean ± standard deviation. The Chi-squared test and 
the Mann-Whitney test were used to compare the groups and considered significant 
when P < 0.05. 
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3.3 Results 
 
3.3.1. The effect of old age and poloxamer 407 on pimonidazole staining 
 
Pimonidazole staining was most often encountered in the pericentral region in livers 
from both young and old F344 rats (Fig. 3.1) and staining intensity increased 
manifold between periportal and pericentral region (Fig. 3.2A, 3.2B, 3.3A). This is 
consistent with the decline in sinusoidal oxygen tension as blood flows from the 
portal vein via zone 2 to the central vein. There were no effects of age on the intensity 
or distribution of pimonidazole staining. Furthermore, there was no effect of 
poloxamer 407 on pimonidazole staining in young Sprague Dawley rats, despite the 
induction of significant defenestration of the LSEC (Fig. 3.2C, 3.2D). 
 
3.3.2. The effect of age on LSEC ATP levels 
 
The ATP content of LSECs isolated from livers from old F344 rats (n = 4) was not 
significantly decreased compared to livers from young F344 rats (n = 4): young 
versus old: 3.6 ± 1.4 nmol versus 2.7 ± 1.8 nmol ATP per 106 cells. 
 
3.3.3. The effect of age on VEGF expression 
 
There was no difference in the expression of VEGF between livers from young (n = 
4) and old (n = 6) F344 rats (Fig. 3.3B, 3.4A, 3.4B). Staining was more intense in the 
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pericentral regions than in the periportal regions and paralleled the distribution of 
staining seen for pimonidazole (Fig. 3.3B, 3.3A).  
 
Figure 3.1. Zonal distribution of pimonidazole staining (hypoxic areas) in young and 
old rats 
Zonal distribution of pimonidazole-adduct immunohistochemical staining in young 
and old rat livers. The distribution is depicted as the % of hypoxic liver zones ± SEM. 
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Figure 3.2. Pimonidazole immunohistochemistry of young and old rat livers 
Pimonidazole immunohistochemistry (light microscopic sections 10×) in livers from: 
(A) Young F344 rat; (B) Old F344 rat; (C) Young Sprague Dawley rat; and (D) 
Young Sprague Dawley rat treated with poloxamer 407. There is zonal gradation of 
staining with increased intensity towards the pericentral regions, but no differential 
effect of ageing or poloxamer 407. 
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Figure 3.3. Quantification and comparison of pimonidazole and VEGF staining in 
livers from young and old rats  
Quantification of pimonidazole (A) and VEGF (B) staining in livers from young and 
old rats shows a zonal gradient in intensity of staining from much less than + in the 
periportal region to about ++ (in a scale ranging over 0, +, ++, +++) in the pericentral 
zone. The intensity of pimonidazole and VEGF immunohistochemical staining in 
young and old rat livers are expressed in arbitrary units ± SEM. There was no 
statistically significant effect of age on the intensity of staining pimonidazole and 
VEGF. 
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3.3.4. The effect of age on VEGFR2 expression 
 
The intensity of sinusoidal and perisinusoidal staining for VEGFR2 was significantly 
increased (P < 0.001) in the livers from old F344 rats (2.5 ± 0.9; Fig. 3.4D, 3.4F; n = 
6) when compared to livers from young F344 rats (1.1 ± 1.1; 3.4C, 3.4E; n = 4). On 
higher magnification (Fig 3.4E, 3.4F), it was observed that there is both increased 
diffuse staining in the LSECs and punctate expression along the sinusoids, possibly in 
LSECs or Kupffer cells or stellate cells. 
 
3.3.5. Scanning electron microscopy 
 
Total fenestration porosity was reduced in the old F344 rats (young 3.4 ± 1.2 %; n = 4 
versus old 2.9 ± 1.5 %; n = 6), P < 0.05, as represented in Fig. 3.4A, 3.4B, with a 
trend towards reduction in fenestration diameter (young 75 ± 11 nm versus old 72 ± 
11 nm, P = 0.07).  
 
Poloxamer 407 reduced the porosity in Sprague Dawley rats (rats without poloxamer 
407, 3.0 ± 1.7 %; n = 5 versus rats with poloxamer 407, 2.2 ± 1.0 %; n = 5), P < 
0.005, as represented in Fig. 3.4C, 3.4D, with no statistically significant effect on 
diameter (80 ± 12 nm versus 77 ± 12 nm, P = 0.2). 
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Figure 3.4. Immunohistochemistry (light microscopic sections 10×) for VEGF and 
VEGFR2 in livers from young and old rats  
Immunohistochemistry (light microscopic sections 10×) for VEGF in livers from 
young (A) and old (B) rats does not show any significant change. 
Immunohistochemistry for VEGFR2 shows in an increase in expression in old (D) 
versus young (C) livers. On higher magnification (40×), the increase in VEGFR2 
expression appears to be related to an increase in staining in liver sinusoidal 
endothelial cells as well as punctate perisinusoidal staining in old (F) versus young 
(E) livers. The full arrow points to a stained sinusoid, the interrupted arrow to a 
stained stellate cell and the arrow-head to a cell displaying Kupffer cell morphology. 
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Figure 3.4. Scanning electron micrographs of sinusoids from livers from young and 
old rat livers as well as young rat livers untreated or treated with poloxamer 407 
Scanning electron micrographs (25000×) of sinusoids from livers from young and old 
rat livers. There is a reduction in number of fenestrations (arrows) in young F344 rats 
(A) compared with old rats (B). Administration of poloxamer 407 reduced the number 
of fenestrations in young control Sprague Dawley rats: (C) Liver from control rat; (D) 
Liver from rat administered Poloxamer 407. The full arrow points at a sieve-plate 
circumscribing many fenestrations. The arrow-head indicates a single fenestration. 
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3.4. Discussion 
 
The role of oxygen in ageing has been studied widely but primarily with respect to its 
role in free radical formation and oxidative stress. Tissue hypoxia secondary to 
vascular disease occurs with ageing (Katschinski, 2006). However there are also a few 
studies directly suggestive of impaired tissue oxygenation in old age. For example in 
the aged kidney, an increase in tissue hypoxia has been detected using pimonidazole 
staining (Tanaka et al, 2006). In the liver, indirect evidence for possible hypoxia 
comes from studies reporting lower levels of ATP measured in liver samples (Le 
Couteur et al, 2001; Selzner et al, 2007) and upregulation of hypoxia-responsive 
genes (Kang et al, 2005). It was suggested that age-related change in the in vivo 
activity of cytochrome P450 enzymes might be evidence of diminished hepatocyte 
oxygenation. Importantly it was hypothesized that age-related pseudocapillarization 
of the liver sinusoidal endothelium might impair oxygen diffusion from the blood to 
the hepatocytes (Le Couteur and McLean, 1998), somewhat similar to the oxygen 
limitation theory of cirrhosis of the liver (McLean and Morgan, 1991). However, in 
this study no evidence was found of intrahepatocytic hypoxia as assessed by 
pimonidazole immunohistochemistry. In addition the effects of the synthetic 
surfactant, poloxamer 407 which reduces fenestrations in the LSEC probably by 
coating the sinusoidal cell membrane (Cogger et al, 2006) was investigated. Although 
this induced a 30% reduction in fenestration porosity with poloxamer 407, it was not 
associated with any change in pimonidazole staining, indicating that convective flow 
of oxygen in plasma through fenestrations is not a rate-limiting step for hepatocyte 
oxygenation. These results do not support the concept of an oxygen diffusion barrier 
generated by age-related changes in the liver sinusoids or LSECs. Therefore, it can be 
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concluded that pseudocapillarization does not pose any significant barrier to oxygen 
uptake and that the age-related decline in ATP in the liver is most likely secondary to 
impaired mitochondrial function. The question arises as to alternate mechanisms for 
the age-related decrease in liver ATP levels. This is possibly attributable to decreased 
liver mass (Schmucker, 2001), mitochondrial oxidative stress (Sastre et al, 2003) or 
mitochondrial dysfunction (Sastre et al, 1996) in aged livers rather than intracellular 
hypoxia. The increased expression of HIF-1α and hypoxia-responsive genes observed 
earlier in the old rat liver (Kang et al, 2005) is unlikely to be secondary to hypoxia, 
and presumably is secondary to other age-related processes such as increased 
production of free radicals. 
 
Pimonidazole has been used to assess hypoxia in many tissues including the liver 
(Arteel et al, 1997; Arteel et al, 1996; Arteel et al, 1995) and nitroimidazole staining 
becomes intense when cellular oxygen partial pressure falls below 10 mmHg (Gross 
et al, 1995). Most staining was in the pericentral region, with a clear gradient of 
intensity from the periportal to pericentral region. Most other studies in the normal 
liver have also shown staining confined to the pericentral region (Arteel et al, 1997; 
Arteel et al, 1995; Rosmorduc et al, 1999; Zhong et al, 2001), which is consistent with 
the loss of oxygen as blood flows down the hepatic sinusoid. Given that hypoxia is a 
potent stimulus for VEGF expression, it would be expected that there is a sinusoidal 
gradient in VEGF that corresponds with pimonidazole staining. Indeed increased 
VEGF expression was seen mostly in the pericentral hepatocytes, which are more 
hypoxic. There have been some similar reports (Corpechot et al, 2002; Maharaj et al, 
2006; Turley et al, 1998), but also a few other reports that failed to find any such 
lobular gradient (Donahower et al, 2006; Ishikawa et al, 1999; Nyska et al, 2002). In 
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this study, the zonal gradation seen in VEGF expression (increasing from the 
periportal zone towards the pericentral zone via zone 2) is consistent with the zonal 
gradation in sinusoidal oxygenation evident in our pimonidazole 
immunohistochemical studies, as well as the metabolic zonal gradation observed in a 
number of previous studies (Jungermann and Kietzmann, 1996; Jungermann and 
Kietzmann, 2000). 
 
The association between ageing and VEGF is of considerable interest because of the 
significant effects it has on new vessel growth. However, the effects of old age on 
VEGF expression are inconsistent, with reports in different tissues of both increased 
expression (Tanaka et al, 2006), and decreased expression (Di Giulio et al, 2005; 
Picciotti et al, 2004; Ryan et al, 2006). In the liver VEGF is especially important 
because of its effects on the LSEC and fenestrations. Hepatocytes produce VEGF and 
the LSECs express both VEGF receptors, VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-
1) where VEGFR2 is the main receptor mediating permeability effects and is 
expressed only on endothelial cells (Ferrara, 2002; Funyu et al, 2001; LeCouter et al, 
2003). Treatment of LSECs with VEGF increases fenestrations two- to fourfold 
(Funyu et al, 2001; Yokomori et al, 2003). On the other hand genetic downregulation 
of VEGFR2 causes a loss of endothelial lining (Gerber et al, 1999) and disrupted 
sinusoids with reduced numbers of fenestrations (Carpenter et al, 2005). Old age is 
associated with marked changes in the LSEC that have been called 
‘pseudocapillarization’ (Le Couteur et al, 2001), including increased thickness of the 
LSEC, reduced fenestrations and altered expression of various endothelial antigens 
and stains (Cogger et al, 2003; Le Couteur et al, 2001; McLean et al, 2003). Therefore 
it was plausible that any age-related reduction in VEGF production by hepatocytes 
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might be important in the pathogenesis of pseudocapillarization. Using Western 
blotting and RT-PCR, it has been reported that VEGF expression is increased in old 
age in the rat (Kang et al, 2005).  However, age-related changes in VEGF in the liver 
were not seen using immunohistochemistry. Whether VEGF is unchanged or 
increased in old age, age-related pseudocapillarization is not secondary to a reduction 
in VEGF production by hepatocytes in old age.  
 
However, there was an increase in the sinusoidal expression of VEGFR2 in the old 
livers and almost no expression in the livers of young animals. The expression in the 
old livers was evident as diffuse staining along the sinusoids almost certainly within 
the LSECs and there was also some perisinusoidal punctate staining. VEGFR2 is 
found exclusively in endothelial cells (Quinn et al, 1993) and in the normal liver, 
VEGFR2 is expressed mostly in the larger vessels, however becomes expressed in the 
LSECs following partial hepatectomy. Recently stellate cells have been reported to 
express both VEGF receptors with upregulation of VEGFR1 following hypoxic 
stimuli (Ankoma-Sey et al, 2000). Our results indicate that old age is also associated 
with upregulation of VEGFR2 in the LSEC. The punctate staining might represent 
either karyomegalic endothelial cells (Nyska et al, 2002), or stellate cells which are 
increased and fat-engorged in old age (Tanuma and Ito, 1978; Vollmar et al, 2002; 
Warren et al, 2005; Yokoi et al, 1984), or Kupffer cells (Yamaguchi et al, 2000). The 
effects of age on VEGFR2 expression have rarely been reported. Expression was 
reported to be unchanged in the inner ear (Picciotti et al, 2004) and increased in the 
corpus cavernosum (Neves et al, 2006). In the liver, genetic downregulation of 
VEGFR2 is associated with defenestration (Carpenter et al, 2005) therefore it is 
unlikely that the age-related increase in VEGFR2 expression is involved in the 
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pathogenesis of pseudocapillarization where fenestrations are reduced in size and 
probably diameter (Le Couteur et al, 2001; McLean et al, 2001). On the other hand, it 
is possible that the increase in VEGFR2 is a compensatory response, perhaps 
attempting to increase fenestrations in response to pseudocapillarization. 
 
Finally the effect of ageing on ATP levels in LSECs was determined. Previously a 
reduction of ATP in whole liver homogenates has been seen (Le Couteur et al, 2001). 
Furthermore, we also found that depletion of ATP by antimycin A caused a marked 
loss of fenestrations in isolated LSECs (Braet et al, 2003). Here we found that old age 
was not associated with any reduction in ATP levels in isolated LSECs. It should be 
noted that the isolation and culture of LSECs may have differential effects in old age 
and the measurement of ATP in isolated LSECs may not represent levels seen in vivo. 
Even so, our results suggest that mitochondrial function is reasonably well preserved 
in old age in this cell type and that ATP depletion is unlikely to be a contributory 
factor in the development of pseudocapillarization. 
 
In conclusion, old age is not associated with hepatocyte hypoxia, LSEC ATP 
depletion or changes in VEGF expression. However, VEGFR2 expression along the 
sinusoids is increased. Therefore age-related reduction in liver ATP levels is more 
likely secondary to mitochondrial dysfunction rather than deficits in oxygen delivery. 
There are no changes in LSEC ATP and hepatocyte production of VEGF that would 
contribute to the pathogenesis of pseudocapillarization of the LSEC. The increase in 
VEGFR2 may reflect a response to age-related pseudocapillarization. 
 
 118 
Table 3.1. Possible  mechanisms and outcomes of age-related hepatic 
pseudocapillarization  
 
Parameters altered with age 
Reviewed in (Le Couteur et al, 2008) 
Relevant 
citations 
Possible mechanisms 
Reviewed in (Le Couteur et al, 2006) 
Relevant 
citations 
Lipoprotein uptake and 
metabolism 
(Hilmer et al, 2005) Primary ageing 
(Le Couteur et al, 
2001) 
Protein and drug uptake 
(Brouwer et al, 1985; 
Ito et al, 2007) 
Systemic vascular disease (Lakatta, 2003) 
Endocytosis (Ito et al, 2007) Mitochondrial parameters (Sastre et al, 2000) 
Immunotolerance 
(Hilmer et al, 2007; 
Ito et al, 2007) 
Dietary factors 
(Clark et al, 1988; 
Fraser et al, 1995) 
Normal adhesion molecule 
expression 
(Ito et al, 2007; Le 
Couteur et al, 2001) 
Age-related vascular 
inflammation 
(Brod, 2000; Hager 
et al, 1994; Paolisso 
et al, 1998) 
Normal hepatic perfusion 
(Brouwer et al, 1985; 
Ito et al, 2007) 
Gram-negative bacterial 
toxic and immune insult 
This study , (Dobbs 
et al, 1994) 
 
 Occult liver disease  
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Chapter 4 
 
Scanning electron microscopic analysis 
of two models of altered liver sinusoidal 
porosity: Diabetes mellitus 1 and 
Calorie-restriction 
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4. Scanning electron microscopic analysis of two models of 
liver sinusoidal porosity intervention: Diabetes mellitus 1 
model and Calorie-restriction model 
 
These two studies were led by Dr. Hamish Jamieson. My contribution to these studies 
was to process baboon and rat liver specimens, perform scanning electron microscopy 
on processed liver specimens, scanning electron micrograph morphometry and 
statistical analysis. These components were pivotal to the studies. 
 
 121 
4.1. Scanning electron microscopic analysis of baboon livers: Diabetes mellitus 1 
model 
 
 
4.1.1. Introduction  
 
Though diabetes mellitus is associated with extensive vascular pathology, little is 
known about its long-term effects on the liver sinusoidal endothelial cell (LSEC). 
Potential diabetic changes in the LSEC are important because of the role of 
fenestrations in the LSEC on the hepatic disposition of lipoproteins. The vascular 
complications of diabetes mellitus are well established and have major clinical 
significance (Singleton et al, 2003). However, little is known about the effects of 
diabetes mellitus on the hepatic microvasculature. In the introductory chapter of this 
thesis, the hepatic microvasculature was described to encompass innumerable porous 
web-like sinusoids that connect afferent portal triads to exiting central hepatic 
venules. These sinusoids form the rich capillary network of the liver, permitting the 
copious hepatic blood flow to flow slowly and intimately between the hepatocyte 
layers (Fraser et al, 1995; Le Couteur et al, 2005). In diabetes mellitus, LSEC 
fenestrations appear to act as conduits for the transfer of some lipoproteins, especially 
chylomicron remnants, between the blood and hepatocytes (Fraser et al, 1995; Le 
Couteur et al, 2002). In old age, there is a substantial loss of fenestrations in the LSEC 
(Cogger et al, 2003; Le Couteur et al, 2001; McLean et al, 2003; Warren et al, 2005), 
which impairs lipoprotein transfer to the hepatocyte (Hilmer et al, 2005). This 
provides a mechanism for age-related impairment in chylomicron remnant clearance 
and post-prandial hypertriglyceridemia, and thus might contribute to the enhanced 
vascular risk of older people (Le Couteur et al, 2002). As such, there are potential 
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parallels with dyslipidemia in diabetes mellitus (Adiels et al, 2006; Battula et al, 
2000; Mamo et al, 1993). The paucity of research into the effects of diabetes mellitus 
on the LSEC probably reflects the considerable risk of liver biopsy in humans. 
Furthermore, many experimental animal models do not fully reflect the metabolic 
changes seen in humans with diabetes mellitus (Goldberg and Dansky, 2006; 
Heffernan et al, 1995). The Australian National Primate colony has a long established 
non-human primate colony (Papio hamadryas) in which type 1 diabetes mellitus was 
induced using streptozotocin administered at an average two years of age (Heffernan 
et al, 1995). Streptozotocin destroys the insulin secreting beta cells of the pancreas 
and creates a hypoinsulinemic, hyperglycaemic state that is similar to type 1 diabetes 
mellitus (Rees and Alcolado, 2005). In many animal models, streptozotocin-induced 
diabetes mellitus has been shown to closely resemble that seen in humans (Heffernan 
et al, 1995) and is generally considered to be an excellent model for the study of type 
1 diabetes (Szkudelski, 2001). The hyperglycaemia in these baboons is partly 
controlled with once daily insulin injections to avoid weight loss and it has been 
possible to obtain a degree of control of type 1 diabetes similar to that in less well 
controlled humans with type 1 diabetes (Heffernan et al, 1995). The diabetic baboons 
have non-diabetic aged-matched controls. Previous data from this same baboon 
colony from the kidney and peripheral nerves has led the researchers to the conclusion 
that the structural and functional changes are similar to those seen in human diabetes 
and different from that of diabetic rats (Birrell et al, 2002; Heffernan et al, 1996). In 
this study, open liver biopsies from diabetic baboons and age-matched controls were 
obtained in order to study the effects of chronic, insulin-treated type 1 diabetes 
mellitus on the ultrastructure of the hepatic microvasculature. The key objective of 
this study was to determine whether diabetes mellitus influences fenestrations in the 
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LSEC because of potential mechanistic implications for diabetic dyslipidemia. 
Surgical liver biopsies for electron microscopy were obtained from baboons with 
long-standing streptozotocin-induced and insulin-treated diabetes mellitus and 
compared with age-matched controls using scanning electron microscopy. 
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4.1.2. Materials and methods  
 
4.1.2.1. Animal protocols and specimen collection 
 
Baboons (Papio hamadryas) were recruited from the National Baboon Colony, 
Sydney, Australia. The animals are members of a breeding colony of P. hamadryas. 
Streptozotocin (60mg/kg, intravenous) had been injected into the baboons at an 
average two years of age to create a diabetic state (Birrell et al, 2002; Heffernan et al, 
1996; Heffernan et al, 1995). Capillary blood glucose levels are measured second 
daily in the diabetic baboons and subcutaneous insulin (human regular and ultralente, 
approximately a total of 4 units) is administered daily according to the trend of 
glucose levels and the glycated hemoglobin (HbA1c) level. The overall target levels 
are a random plasma glucose level of 15 to 30 mmol/L and HbA1c level from 8.0 to 
10.0%, reflecting sub-optimally controlled human type 1 diabetes. All animals are 
housed in family groups and are fed a standard diet and are under the supervision of 
experienced veterinarians. Ethics approval for this procedure was obtained from the 
Central Sydney Area Health Service Animal Welfare Ethics Committee and in 
accordance with the Principles of Laboratory Animal Care (NIH Publication 85-23, 
revised 1985). Four diabetic baboons aged ten to fifteen years, with diabetes duration 
of approximately 10 yrs, were randomly chosen from the colony. Four non-diabetic 
control animals were matched with the diabetic baboons based on age and body 
weight. They were fasted on the night before the procedure. Intramuscular ketamine 
was used to induce general anaesthesia. A 1 cm3 open liver biopsy was taken by an 
experienced human and primate surgeon. Approximately one third of the liver biopsy 
was fixed in 4% phosphate buffered paraformaldehyde. The remaining liver was 
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perfusion-fixed for electron microscopy as previously published (Cogger et al, 2003). 
An aliquot (1-2 ml) of fixative (2% glutaraldehyde and 3% paraformaldehyde in 0.1 
M sodium cacodylate buffer 0.1 M sucrose, 2 mM CaCl2) was injected slowly into the 
liver sample using a 25G needle until the tissue hardened. 
 
4.1.2.2. Scanning electron microscopy 
 
Fixed liver tissue was treated with 1% osmium, dehydrated in an ethanol gradient to 
and incubated for ten minutes in hexamethyldisilazane (Sigma, St Louis, MO). 
Samples were mounted, and then splutter-coasted with gold. Specimens were 
visualized using a Joel JSM 6380 scanning electron microscope. Twelve random 
sinusoids, at 25000 times magnification, were photographed from each liver. All 
scanning electron micrographs were analysed using ImageJ (http://rsb.info.nih.gov/ij/) 
to determine endothelial porosity, average fenestration diameter and fenestration 
density. 
 
4.1.2.3. Statistics 
 
Results are expressed as mean ± standard error of the mean. Comparisons of the blood 
results and electron microscopy data were performed using either the Students t-test 
or Mann-Whitney rank sum test for nonparametric data. Differences were considered 
significant when P < 0.05.  
 
 126 
4.1.3. Results  
 
4.1.3.1. Age, weights and blood results 
Diabetic and control animals were well matched for body weight and age (Table. 4.1). 
Fasting bloods showed significantly elevated HbA1c and glucose in the diabetic 
group. Plasma triglyceride levels were increased substantially (P < 0.05). 
 
Table 4.1. Age, weight and blood tests for control and diabetic baboons 
 
 Controls Diabetics P Value 
Age (years) 12.8 ± 2.21 12.8 ± 2.0 ns 
Weight (kilograms) 22.3 ± 1.2 21.2 ± 2.7 ns 
Glycated haemoglobin (%) 3.6 ± 0.25 7.8 ± 0.7 P < 0.05 
Random plasma glucose (mmol/L) 9.2 ± 2.2 31 ± 6.2 P < 0.05 
Cholesterol (mmol/L) 2.3 ± 0.4 2.8 ± 0.2 P < 0.05 
Triglycerides (mmol/L) 0.3 ± 0.1 2.3 ± 0.65 P < 0.05 
 
Fasting bloods showed statistically significantly elevation of HbA1c, glucose and 
triglyceride. 
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4.1.3.2. Scanning electron microscopy 
 
 The porosity of the LSECs was significantly reduced to nearly one half in the 
diabetic livers (1.4 ± 0.1% versus 2.6 ± 0.2%, P < 0.01, Table. 4.2, Fig. 4.1). This was 
secondary to both a reduction in fenestration diameter and frequency. 
 
Table 4.2. Ultrastructural sinusoidal changes in control versus diabetic baboons 
 
 Controls Diabetics P Value 
Porosity (%) 2.6 ± 0.2 1.4 ± 0.1 < 0.01 
Fenestration diameter (nm) 50 ± 1 43 ± 1 < 0.01 
Fenestration frequency (per µm2) 12.1 ± 0.8 7.8 ± 0.8 < 0.01 
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Figure 4.1. Scanning electron microscope images of liver sinusoids of 
diabetic and age-matched control baboons  
Scanning electron microscope images (20000×) of liver sinusoids in diabetic baboon 
(A) and age-matched control (B). There are fewer fenestrations (→) in the diabetic 
livers.  
 
 
 
Sinusoidal porosity in diabetic rat livers was reduced to nearly 50% of the age- and 
weight- matched controls (P < 0.01). This was secondary to both a reduction in 
fenestration diameter and frequency. 
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4.1.4. Discussion 
 
The streptozotocin-induced diabetic Papio hamadryas baboon colony has proven to 
be a very useful animal model for the study of type 1 diabetes mellitus (Birrell et al, 
2002; Heffernan et al, 1996; Heffernan et al, 1995). In this study, data are presented 
from middle-aged baboons (approximately 13 yrs of age compared with maximum 
life expectancy of 25-30 yrs) that have been treated with insulin for over a decade. 
Blood results revealed the expected features of diabetes mellitus such as elevated 
glucose, HbA1c and markedly elevated triglycerides.  
 
This study focused on the effects of diabetes on the LSEC because recent reports 
indicate an association between pathological changes in the LSEC and dyslipidemia 
(Fraser et al, 1995; Hilmer et al, 2005; Le Couteur et al, 2002). In the diabetic livers, 
the porosity of fenestrations was reduced by about 50%. These are substantial changes 
and are of a similar magnitude to those reported in old age (Cogger et al, 2003; Le 
Couteur et al, 2001; McLean et al, 2003; Warren et al, 2005). The ultrastructural 
changes noted confirm that diabetes mellitus is associated with significant changes in 
the hepatic sinusoid and LSEC. 
 
Although the microvascular complications of diabetes mellitus are well established 
(Singleton et al, 2003), there have been few previous reports of the effects of diabetes 
mellitus on the hepatic microvasculature or that have specifically studied LSEC 
fenestrations. Berneau and colleagues (Bernuau et al, 1982) studied liver biopsies of 
12 insulin-dependent diabetic patients aged 23-56 years. Moderate increases in 
collagen and basal lamina deposition in the space of Disse were reported compared 
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with slightly younger subjects with unconjugated hyperbilirubinemia (aged 31-42 
yrs). Perisinusoidal deposition of collagen was noted, both in the diabetic and non-
diabetic BB rats (Bernuau et al, 1985). In both these reports, the endothelial cells were 
stated to be unaffected. On the other hand, a pilot scanning electron microscopy study 
of rats 8 months after administration of streptozotocin found a small but significant 
increase in fenestration diameter and a reduction in fenestration frequency (Jamieson 
et al, 2001).  
 
This study demonstrates that diabetes mellitus is associated with liver sinusoidal 
defenestration. This has potential implications for liver function, particularly the 
hepatic clearance of lipoproteins such as chylomicron remnants (Fraser et al, 1995). 
One of the initial steps in the metabolism of lipoproteins is that chylomicron remnants 
pass through fenestrations into the Space of Disse for receptor-mediated uptake and 
subsequent processing in hepatocytes. This study demonstrated the strong association 
between loss of porosity and loss of fenestrations with impaired lipoprotein transfer 
across the liver sinusoidal endothelium. Lipoproteins of an average diameter of 56 nm 
freely cross the liver endothelium in young rats. However defenestration associated 
with old age (Hilmer et al, 2005) and treatment with a surfactant, poloxamer 407 
(Cogger et al, 2006) is associated with impaired transfer of lipoproteins and 
hypertriglyceridemia. Delayed chylomicron remnant clearance and subsequent 
postprandial hypertriglyceridemia are features of type I diabetes (Adiels et al, 2006; 
Battula et al, 2000; Mamo et al, 1993). It is thus possible that the substantial loss of 
fenestrations may contribute to this dyslipidemia. A possible explanation as to the 
cause of these changes involves oxidative stress, which is increased in diabetes 
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(Ceriello, 2006), also has marked effects on the structure of the LSEC (Cogger et al, 
2001; Cogger et al, 2004). 
 
In conclusion, there are significant diabetes-related hepatic microvascular changes, 
namely defenestration of the liver sinusoidal endothelium. Such changes are likely to 
have a significant effect on liver function and the clearance of many components of 
the blood, including lipoproteins. This could contribute to the pathogenesis of 
systemic macrovascular disease associated with diabetes mellitus. 
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4.2. Scanning electron microscopic analysis of rat livers: Calorie-restriction 
model 
 
4.2.1. Introduction 
 
The implications of age-related impairment in liver function are well recognized (Le 
Couteur et al, 2005; Schmucker, 2005). One mechanism for this change is age-related 
alterations in the ultrastructure of the liver sinusoidal endothelium (Le Couteur et al, 
2005). The liver sinusoidal endothelium of young adults is very thin and perforated by 
fenestrations. In old age, there is a 30-50% reduction in the area of the endothelium 
perforated by fenestrations (‘porosity’). This is associated with increased endothelial 
thickness and extracellular matrix in the space of Disse, including collagen and basal 
lamina (Cogger et al, 2003; Le Couteur et al, 2001; McLean et al, 2003; Warren et al, 
2005). All of these age-related changes have been termed age-related 
pseudocapillarization, reflecting the shift to a typical capillary morphology. The 
thickened endothelium and defenestration are likely to reduce the transfer of many 
substrates between the sinusoid and hepatocytes (Le Couteur et al, 2005), particularly 
lipoproteins (Hilmer et al, 2005; Le Couteur et al, 2002). It was recently shown that 
the loss of fenestrations in old age impedes the transfer of some lipoproteins from the 
blood to the hepatocytes, which provides a mechanism for age-related postprandial 
hypertriglyceridemia and impaired chylomicron remnant clearance (Hilmer et al, 
2005; Huet and Villeneuve, 2005). Therefore it is of therapeutic interest to determine 
whether pseudocapillarization is preventable through the effects of caloric restriction 
(CR). 
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CR increases longevity and those physiological and pathological changes delayed by 
CR are generally considered to be an integral part of the ageing process (Ingram et al, 
2004; Masoro, 2005; Sinclair, 2005). Reducing caloric intake delays the onset of age-
related diseases and increase maximum lifespan by between 20% and 40% in many 
species (Everitt et al, 2005). CR influences lipoprotein profiles and the onset of 
vascular disease in animal models (Zhu et al, 2004) and similar effects have replicated 
in short term studies in humans (Heilbronn et al, 2006). 
 
One mechanism for the effects of CR on lipoprotein metabolism and susceptibility to 
vascular disease might be related to its effects on the liver sinusoidal endothelium (Le 
Couteur et al, 2001). The liver sinusoidal endothelium is exquisitely sensitive to 
oxidative stress (Cogger et al, 2001; Cogger et al, 2004) and other toxic insults 
(McCuskey, 2006). Thus, it is plausible that the structure of the liver sinusoidal 
endothelium may be profoundly influenced by the quantity of the dietary load, with its 
concomitant oxidants and toxins delivered to it via the portal vein. The study 
described here assessed whether CR reduces age-related pseudocapillarization of the 
liver sinusoidal endothelium. 
 
Since age-related hepatic pseudocapillarization may contribute to the pathogenesis of 
dyslipidemia and since CR is a powerful model for the study of ageing as it extends 
lifespan; assessment of the effects of CR on the hepatic sinusoid was done to 
determine whether pseudocapillarization is preventable. This may unravel a possible 
novel target for the prevention of age-related dyslipidemia.  
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4.2.2. Materials and methods  
 
4.2.2.1. Animal protocols and specimen collection 
 
Young (6 months) and old (24 month) CR and AL Fisher F344 rats were obtained 
from the National Institute on Aging (Baltimore, Maryland) derived from stock from 
the National Institutes of Health and Harlan Sprague Dawley Inc. The rats were 
specific pathogen free. They were barrier maintained with a 12-hour light/dark cycle 
and fed sterilized NIH 31 rat chow. CR was started at weaning and increased at 10% 
per week. Forty percent CR was reached at 2.5 months. The CR rats were then 
maintained on a 40% CR diet. The research had the ethical approval of the Animal 
Care and Users Committee of the National Institute on Aging. 
 
The liver samples were obtained from these rats under anesthesia with pentobarbital 
(60 mg/kg, I.P.). Segments of the liver were perfused for 10 min with electron 
microscope fixative solution (3% glutaraldehyde, 2% paraformaldehyde, 2 mM 
calcium chloride, 1% sucrose in 0.1 M sodium cacodylate buffer). Following fixation, 
1 mm3 samples were taken, post-fixed, washed and then stored in 0.1M sodium 
cacodylate buffer at 4°C.  
 
4.2.2.2. Scanning electron microscopy 
 
Preparations of samples for scanning electron microscopy was performed as 
previously described (Cogger et al, 2003; Le Couteur et al, 2001; Warren et al, 2005). 
Fixed tissue was treated with 1% osmium tetroxide in 0.1 M sodium cacodylate buffer 
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for two hours, dehydrated in an ethanol gradient and treated for 10 minutes in 
hexamethyldisilazane (Sigma, St Louis, MO). Six random samples from each liver 
were sputter-coated with gold. Samples were examined using a Joel JSM 6380 
Scanning electron microscope. Ten random sinusoids (magnification × 25000) were 
photographed from each liver. Analysis of porosity, fenestration diameter and 
fenestration frequency was made using the ImageJ image analysis program obtained 
from NIH (http://rsb.info.nih.gov/ij/). The total numbers of fenestrations counted in 
the scanning electron microscopic study were 2777 for young AL, 6291 young CR, 
6290 for old AL and 5114 for old CR rats.  
 
4.1.2.3. Statistics 
 
Results of the image analysis are presented as the mean of the values for each field 
analyzed ± standard error of the mean. The P values reported are those derived from 
the Student-Newman-Keuls method if one-way ANOVA showed a significant 
difference (P<0.05) between the observations in the four groups. Two-way ANOVA 
was used to analyse the interaction between age and response to caloric restriction. 
Statistical calculations were performed using Sigmastat version 2.03 (SPSS Inc, CA). 
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4.2.3. Results  
 
4.2.3.1. Animal particulars 
 
The liver and body weights are shown in Table. 4.3. Liver weight was significantly 
lower in the CR rats both at 6 and 24 months of age. Five out of eleven old AL rats 
and one out of five old CR rat were excluded from all analyses because of the 
presence of an extensive myeloproliferative infiltrate in the liver and spleen with 
substantial splenomegaly that has been reported to occur very frequently in old F344 
rats (Sass et al, 1975). 
 
Table 4.3. Liver and body weights for the young and old, CR and AL F344 rats 
 
 
 
 
 
 
 
 
 
Parameter Young AL 
(n=5) 
Young CR 
(n=5) 
Old AL 
(n=6) 
Old CR 
(n=4) 
Body weight (g) 368 ± 12 214 ± 4 396 ± 21 291 ± 11 
Liver weight (g) 10.9 ± 1.1 5.1 ± 0.4 13.1 ± 0.9 6.9 ± 0.6 
Liver weight 
(% of body weight) 
3.0 ± 0.2 2.4 ± 0.2 3.3 ± 0.1 2.4 ± 0.1 
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4.2.3.2. Scanning electron microscopy 
 
The results of the image analysis of the electron microscopy are shown in Table 4.4 
and representative micrographs are shown in Fig. 4.2. Old age was associated with 
reduced fenestration porosity in AL rats. CR rats had greater porosity than AL rats at 
both 6 and 24 months of age. Two-way ANOVA showed there was a significant 
difference between the four groups (P<0.001); both age and CR influenced porosity 
(P<0.001 for both); and age did not influence the response to CR (ns). The changes in 
fenestration porosity appeared to be mediated mostly by changes in the frequency of 
the fenestrations rather than their diameters (Table. 4.4).  
 
Table 4.4. Scanning electron micrograph analysis of the effects of ageing and CR on 
the liver sinusoidal endothelium 
 
 
Old AL was significantly less than young AL (P < 0.001) and old CR (P < 0.001). 
Young CR was significantly greater than young AL (P < 0.001). 
 
Parameter Young AL Young CR Old AL Old CR 
Porosity (%) 3.4 ± 0.3 4.3 ± 0.2 2.4 ± 0.1 3.9 ± 0.3 
No. of Fenestrations/ µm2 8.0 ± 0.6 10.8 ± 0.8 6.3 ± 0.4 10.9 ± 0.6 
Fenestration Diameter (nm) 68 ± 1 67 ± 1 66 ± 2 62 ± 1 
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Figure 4.2. Scanning electron microscope images of sinusoids of young CR 
(YCR), young AL (YAL), old CR (OCR) and old AL (OAL) rats  
Scanning electron micrographs (25000×) of livers from young CR (YCR), young AL 
(YAL), old CR (OCR) and old AL (OAL) rats. Old age was associated with reduced 
fenestration porosity in AL rats. CR rats had greater porosity than AL rats at both 6 
and 24 months of age.  
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4.2.4. Discussion 
 
The major findings of this study are: (1) confirmation of the presence of significant 
liver sinusoidal changes in old age in rats; (2) CR delays such changes at least until 
the age of 24 months; and (3) the effects of CR on the liver sinusoidal endothelial cell 
are apparent early in life. 
 
Previous reports showing age-related changes ultrastructural changes in liver 
sinusoidal endothelium in rats (Le Couteur et al, 2001), non-human primates (Cogger 
et al, 2003), mice (Ito et al, 2005; Warren et al, 2005) and humans (McLean et al, 
2003) were confirmed in this study. This study revealed that CR rats had a higher 
porosity at 24 months of age (3.9 ± 0.1%) compared to AL rats (2.4 ± 0.1%, P<0.01) 
implying that CR had a dramatic preserving effect on the morphological 
characteristics of young liver sinusoidal endothelium in terms of endothelial porosity. 
This provides a crucial mechanism for the effects of CR on lipids and vascular 
disease. One of the most important functions of fenestrations appears to be related to 
the transfer of chylomicrons remnants across the endothelium for subsequent hepatic 
metabolism (Fraser et al, 1986). This transfer of lipoproteins is very impaired in old 
age (Hilmer et al, 2005). The preservation of fenestrations by CR will presumptively 
be associated with improved hepatic clearance of chylomicron remnants and hence, 
less risk of developing systemic vascular disease. 
 
The effects of CR on fenestration porosity were seen relatively early in the lifespan. 
At six months of age, fenestration porosity was significantly increased in the CR rats 
(4.3 ± 1.4%) compared to the AL rats (3.4 ± 1.5%, P<0.01).  
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In conclusion, ageing is associated with significant ultramicroscopic morphological 
changes in liver and CR prevents the age-related decreases in fenestration porosity 
indicating that these changes are intrinsically part of the ageing process. Intriguingly, 
CR resulted in a higher porosity than AL fed animals apparent even at 6 months, 
which suggests that the liver sinusoidal endothelium may contribute to the beneficial 
effects of CR in later life. Furthermore, the prevention of age-related 
pseudocapillarization by CR shows that it is a plausible therapeutic target for the 
amelioration or prevention of age-related dyslipidemia. 
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Chapter 5 
 
Conclusions 
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5. Conclusions 
 
The studies presented in this thesis underscore the pivotal role of the liver sinusoidal 
endothelium and fenestrations in the pathophysiology of bacterial toxin-induced 
injury as well as septicaemia-related, ageing-related and post-prandial 
hyperlipidemias. In addition the results suggest novel therapeutic strategies for these 
conditions. 
 
In chapter 2, it was shown that pyocyanin treatment over a wide range of 
concentrations is associated with a substantial loss of LSEC porosity. Pyocyanin also 
induces significant acute changes in the in vivo liver sinusoidal endothelium without 
any morphological hepatocellular alterations including mitochondrial morphology and 
frequency or any other signs of hepatocyte injury or oxidative stress. These LSEC 
changes were not accompanied by evidence of structural, biochemical hepatocellular 
changes or changes in the fenestration constituent protein, caveolin-1. In addition, a 
decrease in endothelial thickness with pyocyanin was noted, a change that has not 
been reported with any other toxic injury to the LSEC. These findings indicate that 
the LSEC is initial site of injury induced by pyocyanin, and indeed may even have a 
role in protecting hepatocytes from endo- and xenobiotics. Damage to the liver 
sinusoids and LSECs induced by pyocyanin could impact graft outcome and 
prognosis following pseudomonal sepsis. The results also support the concept that 
hyperlipidemia associated with sepsis might in part be a result of LSEC 
defenestration. 
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In chapter 3, the hypothesis that age-related pseudocapillarization of the liver 
sinusoidal endothelium might impair oxygen diffusion from the blood to the 
hepatocytes was examined to account for the decreased phase 1 metabolism, decrease 
in ATP levels and increased expression of hypoxia-responsive genes in aged human 
and animal livers. Using pimonidazole immunohistochemistry for in vivo detection of 
tissue hypoxia, it was shown that age-related liver sinusoidal pseudocapillarization 
does not pose any significant barrier to oxygen uptake and that the age-related decline 
in ATP in the liver is most likely secondary to impaired mitochondrial function. In 
this study, the zonal gradation seen in VEGF expression was consistent with the zonal 
gradation of hepatic hypoxia. However, there was an increase in the sinusoidal 
expression of VEGFR2 in the old livers and almost no expression in the livers of 
young animals. It is possible that the increase in VEGFR2 is a compensatory 
response, perhaps attempting to increase fenestrations in response to 
pseudocapillarization. 
 
In chapter 4, using a baboon model it was demonsrated that type 1 diabetes mellitus 
was associated with liver sinusoidal defenestration and therefore of significance for 
liver function, particularly the hepatic clearance of lipoproteins. Since delayed 
lipoprotein clearance and subsequent postprandial hypertriglyceridemia are features of 
type I diabetes, it is possible that the sinusoidal defenestration in diabetes mellitus 
may be an important mechanism. Such changes are likely to have a significant effect 
on liver function, blood lipoprotein clearance and the pathogenesis of systemic 
macrovascular disease in type 1 diabetes mellitus. 
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In chapter 4, using a CR rat model, it was shown CR prevents age-related decreases in 
fenestration porosity. CR also resulted in a higher porosity than AL fed animals very 
early on, which suggests that the liver sinusoidal endothelium may contribute to the 
beneficial effects of CR in later life. The prevention of age-related 
pseudocapillarization by CR shows that CR could be a plausible therapeutic target for 
the prevention or amelioration of dyslipidemia associated with ageing. 
 
These studies examine the crucial role of the liver sinusoids and LSECs in 
pathogenesis of disease in bacterial infections and ageing. Future studies should aspire 
to evaluate LSEC fenestration biology and pathophysiological mechanisms for 
changes in fenestrations in disease and ageing. The ensuing data may permit 
development of potential therapeutic targets and agents that may prevent or alter 
LSEC fenestration morphology and pathology in various disease states, including 
sepsis, transplantation, diabetes mellitus and ageing. 
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6. Protocols and criteria-sheets involving my innovations 
and modifications  
 
6.1. Chemical synthesis of pyocyanin 
 
1. 100 ml of 10 mM TRIS HCl prepared 
a. MW of TRIS HCl= 158 
b. 1 M TRIS HCl= 158 g/1000ml= 0.158 g/ml 
c. 10 mM TRIS HCl= 0.00158 g/ml= 0.158 g/100ml 
2. 100 mg PMS added to 100 ml of 10 mM TRIS HCl in a 100 ml capacity thin 
stemmed round bottomed glass flask 
3. PH to 7.4 
4. The reaction mixture kept adjacent to a daylight fluorescent tube light for 2.5 
hours. The following specific brand details of the tube light was preferred 
a. Phillips TLD 18 W/54 
b. Thailand  
c. TIS.958-2533 
d. TIS.236-2533 
5. Chloroform added to the reaction mixture in a separation funnel kept in a fume 
hood (adjusting the ratios or number of sequences) 
6. The lower chloroform (organic) phase with pyocyanin transferred to a pear-shaped 
flask 
7. Nitrogen bubbled through the contents of the pear-shaped flask till a blue 
pyocyanin sludge remains after all the chloroform has been evaporated 
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8. Blue pyocyanin sludge resuspended in 50 ml chloroform 
9. 0.1 M (that is, 0.1 N) HCl prepared 
a. 6.25 ml of 16 M stock HCl solution mixed with 93.75 ml of Millipore 
water to give a 1 M HCl solution 
b. 0.1 M HCl solution prepared by adding 10 ml of 1 M HCl solution to 90 
ml of Millipore water 
10. Pyocyanin chloroform solution acidified with 50 ml of 0.1 M HCl 
11. 50 ml of chloroform added 
12. 0.5 M (that is 0.5 N) NaOH prepared 
a. 1 M NaOH consists of 40 g in 1000 ml of water 
b. 20 ml of 0.5 M NaOH prepared by adding 0.4 g of NaOH (2 NaOH 
pellets) to 20 ml of Millipore water 
13. Few drops of 500 mM NaOH added 
14. Chloroform extraction done twice with 50 ml chloroform 
15. Pyocyanin chloroform solution kept at –20°C freezer overnight  
16. Chloroform evaporated  
17. Pyocyanin resuspended in small amounts of more chloroform 
18. Pyocyanin chloroform (concentrated) solution transferred to a vertical Pyrex glass 
tube 
19. Chloroform evaporated 
20. Hexane wash done by adding hexane (pyocyanin is insoluble in hexane), swirling 
the tube, and aspirating the hexane out 
21. Chloroform (SMALL volume) added to pyocyanin 
22. Hexane (large volume) added SLOWLY, DROP by DROP to the pyocyanin 
chloroform solution 
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23. 10 minutes waiting period mandated 
24. Pyocyanin crystallized automatically 
25. Pyocyanin in hexane and chloroform is centrifuged at 5000 rpm in 50 ml 
polypropylene tubes  
26. Supernatant pipetted out from the 50 ml tubes and discarded 
27. Lower phase with the pyocyanin crystals transferred to a polypropylene syringe 
(without a piston) with its tip compactly fitted into a the top nozzle of a filter 
apparatus containing a type EH 0.5 µ filter 
28. Pyocyanin crystals trapped by filter 
29. Methanol elution into a screw-capped glass bottle done 
30. Methanol evaporated by nitrogen bubbling 
31. Small amount of methanol used to dissolve the pyocyanin 
32. Pyocyanin methanol solution kept at –20°C freezer overnight 
33. Methanol evaporated by nitrogen bubbling 
34. Pyocyanin reconstituted in a small amount of chloroform 
35. Silica glass TLC plate activated  
a. TLC plates from Merck (HPTLC Pre-coated Silica Gel 60 Plates) used 
b. Excess silica from 3 edges scraped out 
c. TLC plate kept vertically in 10 ml methanol in a glass cage without paper 
lining. The most jagged/ damaged edge placed inferior and in contact with 
methanol in the glass cage. Glass plate used to cover the glass cage 
d. TLC plate is taken out of the methanol (and the glass cage) as soon as the 
solvent (methanol) front reaches 2 cm from the top edge (of the TLC plate) 
e. TLC plate kept outside the glass cage, inside the hood, for 10 minutes 
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f. TLC plate kept on a folded A4 size paper and heated with silica side up in 
a microwave at power setting 2 for 5 minutes 
g. TLC plate heated in the microwave at power setting 3 for 10 more minutes 
h. TLC plate kept in the dark or inside a desiccator till use 
36. Sample applicator (Camag Nanomat) fitted with a applicator syringe fitted with a 
1 µl (preferably) or a 5 µl glass tip, utilized to apply pyocyanin chloroform 
solution to the silica part of the silica glass TLC plate 
37. TLC plate with loaded pyocyanin kept in chloroform methanol mixture (12.5 ml: 
12.5ml) inside a glass cage with a paper lining 
38. TLC plate removed from the glass cage when the solvent front reaches 2 cm from 
the top edge 
39. TLC plate computer-scanned and image saved 
40. Silica layer with the pyocyanin carefully scraped from the glass part of the TLC 
plate 
41. Scraped silica with pyocyanin dissolved in 2 cm methanol in a screw capped glass 
bottle 
42. Silica pyocyanin methanol solution transferred to small glass tubes (compatible in 
the slots of the centrifuge to be described soon) 
43. Glass tubes centrifuged twice in the centrifuge available inside the walk-in 
refrigerator (the sealing lid is not shut, only the topmost trap lid is shut) 
44. Shimadzu Spectrophotometer Precautions 
a. Remember that only the proximal slot is for the test sample(s) and the 
distal slot is for the blank 
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b. While calibrating and taking absorption measurements Blanking (or 
Baselining) should be done with blanks at both the proximal slot and the 
distal slot prior to taking the test sample(s) reading 
c. A Deuterium Lamp emits UV light with wavelength ranging from 200-350 
nm. A Halogen Lamp emits visible range light with wavelength ranging 
from 350-800 nm. Adjustments of the wavelengths should be made such 
that no absorbance peak occurs at the junction of the UV light spectra and 
the visible range light spectra 
d. Only quartz cuvettes are to be used. The Normal (1 ml) cuvette is preferred 
to the Small or Semimicro cuvettes 
45. Shimadzu Spectrophotometer Preparations 
a. Check the spectrophotometer slots to see if they are empty first 
b. Switch the spectrophotometer on (Switch on the left flank) 
c. Click F4 on the spectrophotometer (This connects it to the computer) 
46. Computer Manipulation of Spectrophotometer Functioning 
a. Programs 
b. Shimadzu 
c. UV120 IPC 
d. Acquire Mode 
e. Spectrum: The calibrations should be as follows: 
i. Measuring Mode:   Abs 
ii. Recording Range:   Low 0.0 to High 0.5 
iii. Wavelength Range (nm):  800 to 200 nm 
iv. Scan Speed:    Fast 
v. Sampling Interval nm:   1 
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47. Spectrophotometric Estimation of Pyocyanin Concentration 
a. Only quartz cuvettes are to be used. The Normal (1 ml) cuvette is preferred 
to the Small or Semimicro cuvettes  
b. Use 2 cuvettes filled with methanol in each to blank (baseline). Place 
cuvette 1 in the proximal slot and cuvette 2 in the distal slot of the 
spectrophotometer 
c. Blanking (baselining) is done by clicking Baseline 
d. To check whether the blanking was done properly, click Start. The 
absorbance value should be 0 
e. Dilute pyocyanin in methanol to 1: 100 dilution (10µl: 990µl) in cuvette 1 
(from proximal slot in the spectrophotometer). This is the sample cuvette. 
Place the sample cuvette in the proximal slot in the spectrophotometer 
f. Click Start 
g. Pyocyanin typically peaks at 718 nm, 318 nm and 239 nm. The absorption 
values at these spectra are noted 
48. Calculation of Molar Concentration using Spectrophotometer Absorption Data  
a. Adjust the concentration of pyocyanin (by drying the methanol using 
nitrogen surface insufflation in a Fume Hood and/ or by adding more 
methanol) till a 1 mM concentration is obtained. The millimolar 
concentration of pyocyanin solution in methanol can be determined as 
follows 
b. Please note that extinction coefficients depend on the solvent used and the 
specific wavelength of absorption spectra 
i. Different solvents have different Extinction Coefficients 
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ii. Different Absorption wavelengths have different Extinction 
Coefficients 
c. Absorbance = Molar Concentration × Light path × Extinction Coefficient  
d. A = E × L × C = E × 1 Cm × C = EC  
e. Therefore the Molar Concentration C = A / E × Dilution Factor = A / E × 
100 
f. The absorption values obtained were as follows: 
 
Wavelength (nm) Absorption 
718  
318  
239  
 
g. The typically used absorption wavelength of pyocyanin for calculation of 
Molar concentration is at 318 nm, because that is where the highest peak is 
seen 
h. The Extinction Coefficient E of pyocyanin in methanol at 318 nm is 
30199.5 
i. Therefore the millimolar concentration of pyocyanin is 1 mM 
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Absorption Spectrum of Purified Pyocyanin
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Blue pyocyanin band on TLC Plate 
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6.2. Image analysis using ImageJ 
 
METHOD FOR IMAGE ANALYSIS- PRELIMINARY STEPS 
 
1. Open image J program 
2. Open a Tiff Image first 
3. To set scale click on ANALYZE then SET SCALE 
a. Set scale depending on magnification picture was taken at  
 
Magnification SEM Scale 
6,000 0.6 pixels/nm 
15,000 0.15 pixels/nm 
25,000  0.25 pixels/nm 
 
Magnification TEM Scale 
4,600 0.069 pixels/nm 
19,000 0.269 pixels/nm 
 
b. Select global on the set scale page 
4. On image J select the “love heart shape” 
a. On the image, pick the area that is SINUSOIDAL ENDOTHELIUM 
WITHOUT ANY RIPS 
b. Hold the left button on the mouse down while you encircle the appropriate 
area on the image 
c. When finished lift the button on the mouse up. 
5. Select EDIT then CLEAR IMAGE 
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6. Select ANALYSIS and MEASURE to measure area. 
7. Cut the AREA measurement out and paste it into EXCEL. 
 
MEASURING THE FENESTRATIONS (Best done in quadrants) 
 
8. Enlarge the image to 100% by selecting the magnifying glass on the tool bar and 
then left clicking twice on the image.  At the top of the image you will not see any 
magnification size on the image (you can alter the image size and increase it by 
left clicks on the mouse and decrease it by right clicks). 
9. Use the scroll icon and move one quadrant into the screen only. 
10. Select the line icon.  AFTER YOU DO THIS YOU NEED TO CLICK ON A 
LINE OUTSIDE THE AREA OF THE IMAGE 
11. Scroll down each fenestrations along its maximum diameter.  After each diameter 
has a line down it, push the “M” key to measure it. 
12. Careful to measure each fenestrations once and only once 
13. When you have completed a quadrant, move to the next quadrant and measure the 
fenestrations.  To move to the next quadrant select the scroll icon then left click on 
the image and move it.   When the next quadrant is in view select the line icon and 
scroll down the length of each fenestrations then click “M” 
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COLLATING DATA 
 
 
14. When all the fenestrations have been measured go to RESULTS page; then click 
EDIT; and then click SELECT ALL.  Cut all the results out and paste them into 
EXCEL.  Remember the first number on each line is the number of fenestrations 
and the last number is the diameter. 
15. To Convert diameter to area apply the formula: 
a. Eg to convert a diameter in e2 and give the result in f2 then in f2 put =(0.5 
× e2 × 0.5 × e2 × 3.14 × 0.5) 
b. Copy this for all the diameters 
 
STATISTICS: CALCULATING AVERAGES 
 
1. Calculate average fenestration diameter (in nm) 
2. Calculate porosity of the endothelium (in %).  To do this: 
a. Calculate the TOTAL AREAS of all fenestrations 
b. Porosity is AREA OF ALL FENESTRATIONS/ AREA OF 
ENDOTHELIUM × 100 
3. Calculate the number of fenestrations per square micrometer.   
a. This is number of fenestrations / area of sinusoid (in nm) × 1,000,000 
b. Note this is conventionally expressed fenestration s/ µm2, not fenestrations 
/ nm2 so the results needs to be multiplied by 1,000,000.  
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6.3. Preparation of isolated rat LSECs  
 
LSEC PREPARATION- MATERIALS 
 
1. Sterile Bag 1: 2 Straight Forceps 
2. Sterile Bag 2: 5 Mosquito Artery Forceps, 1 Broad-end Scissors, 1 Sharp-end 
Scissors, 2 Forceps 
3. HBSS for initial rat liver perfusion 
• HBSS Should NOT have Ca2+ 
4. Collagenase solution (A) – make up 100 ml of 0.05 % collagenase (50 mg) in 
HBSS (with Ca2+), neutralize the non-specific proteases with 5% FCS 
• Should be prepared just before experiment 
• HBSS SHOULD have Ca2+ 
5. Collagenase solution (B) – Make up 50 ml of 0.05% collagenase (25 mg) and 
0.001% DN'ase [DN’ase added as a ”pinch” just before use] and 2.7 ml FCS in 
HBSS (with Ca2+) 
• Should be prepared just before experiment 
• HBSS SHOULD have Ca2+ 
6. Stock Percoll – Prepare stock Percoll solution (SPS) by mixing 10 ml of 10-fold 
concentrated (10 X) Dulbecco’s PBS (no Ca2+) with 90 ml Percoll 
• Can be prepared 1 day before experiment 
• 10 X Dulbecco’s PBS should NOT have Ca2+ 
• Prepare 30 ml of SPS (3 ml 10X Dulbecco’s PBS 3 ml + 27 ml Percoll) 
7. Percoll gradient prepared just before experiment – Do duplicates 
• Dulbecco’s PBS should NOT have Ca2+ 
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• EACH Percoll gradient consists of: 
i. Upper layer 20 ml 25% Percoll: Obtained by mixing 5 ml SPS and 
15 ml PBS 
ii. Lower layer 15 ml 50% Percoll: Obtained by mixing 7.5 ml SPS 
and 7.5 ml PBS 
• Therefore, prepare a total (for duplicates) of: 
i. 40 ml of 25% Percoll: Obtained by mixing 10 ml SPS and 30 ml 
PBS 
ii. 30 ml of 50% Percoll: Obtained by mixing 15 ml SPS and 15 ml 
PBS 
8. Complete RPMI-1640 with Glutamine (0.02 g/100ml), 2% FCS (heat-inactivated), 
antibiotics (1 ml/ 100 ml) (100 U/ml penicillin, 100 µg/ml streptomycin) 
9. Collagen solution for wells and coverslips. Use Collagen-S solution as substrate 
for the culture of LSECs by equally distributing it on the plastic surface of the 
wells or coverslips. After 18 hours at 4°C, rinse the coverslips with RPMI-1640 
leaving behind a thin film of collagen. 
 
LSEC PREPARATION- METHODS 
 
1. Anaesthetize a rat (Male Sprague- Dawley, 250-350 g) intraperitoneally with 0 .5 
ml [1 ml/ kg weight of rat] out of a total of 1ml in an insulin syringe that consists 
of: 
a. 40mg (0.6ml on 100mg/ml) Ketamine 
b. 4mg (0.06ml of 100mg/ml) Xylazil 
c. 0.34 ml saline 
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2. Administer heparin (150 U-a pinch with 0.3 ml normal saline) into inferior 
mesenteric vein 
3. After laparotomy, insert and secure a 18G catheter into the portal vein  
4. Cut the inferior vena cava beneath the liver immediately cut and start perfusion 
with 39°C HBSS (no Ca2+) 
5. Flush 200 ml HBSS (no Ca2+) through the liver at a flow rate of 10 ml/min. - 200 
ml can also be 150, 100 ml, or even 75 ml; from the moment the liver is 
completely discolored (from red/purple to brown/ochre) 
6. Perfuse liver with HBSS (with Ca2+, 100 ml) collagenase solution at a flow rate of 
5 ml/min 
7. Remove liver after 20-25 minutes 
8. Discard Glisson's capsule along with the vessels with the aid of forceps 
9. Disrupt the paste-like liver substance further disrupted by mincing it between 
forceps 
10. Shake the forceps-minced paste-like liver substance (gently) in 10 ml of fresh 
Collagenase B solution [HBSS (with Ca2+) containing 0.05% collagenase, 0.001% 
DN'ase (added as a “pinch” just before use), and FCS] for approximately 10 min 
at 39°C. Repeat 4 times, each time filtering using the following step (9): 
a. Each time, the cell suspension is filtered through nylon gauze (mesh 100) 
to remove undigested tissue 
b. Don’t exceed a total incubation time of 30 minutes, including RT AND 
Incubator steps 
11. Centrifuge cell suspension at 100 g for 5 min at 20° (break low) to remove most 
hepatocytes 
12. Centrifuge supernatant (enriched in sinusoidal cells) for 10 min. at 350 g 
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13. Resuspend cell pellet in 50 ml PBS and centrifuge again for 10 min at 350 g 
14. Resuspend the resulting cell pellet in 20 ml PBS 
15. Layer 10 ml of the cell suspension on top of each of the two-step Percoll gradient 
16. Centrifuge gradients immediately at 900 g for 20 min (break off) 
17. Discard top layer (45 ml to 25 ml) FIRST, and use a sterile Pasteur pipette to 
collect the intermediate zone (25 ml to 10 ml layer; between the two density 
layers; especially around the 15 cm mark), which is enriched in LSECs 
18. Dilute these enriched LSECs with an equal volume of PBS & centrifuge at 900 g 
for 10 min 
19. Resuspend the resulting cell pellet in 10 ml culture medium. Pipette the resulting 
cell suspension into FOUR 5 cm diameter tissue grade petridishes without any 
coating 
20. Incubate the petridishes for 7-8 min ONLY (NOT MORE than 10 min) at 37°C in 
a humidified incubator under 5% CO2 in air, to allow the selective attachment of 
the Kupffer cells 
21. Collect LSECs by REALLY firmly (NOT too firmly!) washing the wells; 
otherwise ↓ yield;  
22. LSEC count calculation: 
a. 50 µl cell suspension + 450 µl Trypan blue (Dilution is *10) and mix well 
b. Add sufficient quantity (less than 50 µl) to Improved Neubauer chamber 
with cover slip already in place. Before loading, add a drop of water to 
each side groove of Neubauer Chamber to enhance cover-slip grip (to the 
Neubauer chamber) 
c. Count the LSECs in all the 4 corners of the grid (n) 
d. Total Cell Count= n/4* 10 * 104 per ml 
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e. 1 ml (STRICTLY:- no more volume, no less volume!) at 0.80x106 
LSECs/ml (semi-confluent) or 1.60x106 LSEC/ml (confluent) is seeded on 
collagen-coated cover slips  
f. If cell-suspension is to be concentrated to bring to the appropriate cell 
density for seeding the wells with cover-slips, centrifuge at 250 g for 10 
minutes, and resuspend cell pellet in apt volume of media 
23. Do a media change 2-4 hours after plating to wash the culture (gently) and further 
changes occurred at 24-hour intervals subsequently 
24. Cells are preferably used ASAP (6-12 hours post inoculation) 
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6.4. Processing of LSECs for scanning electron microscopy  
 
1. Fix cells with 4% EM grade Glutaraldehyde in 0.2 M Na-Cacodylate buffer with 
0.1M sucrose (IMPORTANT!) 
a. 1 ml for each cover slip 
b. 5 ml for 5 coverslips 
c. 5 ml contains 0.8 ml 25% glutaraldehyde, 2.5 ml 0.2 M  Na-Cacodylate 
buffer, 1.7 ml of Millipore water, and 0.17 g sucrose 
i. Stock glutaraldehyde= 25% 
ii. 1% glutaraldehyde= 4 ml in 100 ml 
iii. 4% glutaraldehyde= 16 ml in 100 ml 
iv. 4% glutaraldehyde= 16/20 in 5 ml= 0.8 ml in 5 ml 
2. Allow to fix for about 4hours in the fridge or 1hr at room temperature 
3. [Carry on with the following steps if time is available. If not, keep cells in 0.1M 
Na-Cacodylate buffer in fridge ovenight and on the next day, do 2 washes in 0.1M 
Na-Cacodylate buffer, not 3, as in the case of the regular protocol] 
4. Wash 3 x 5 minutes in 0.1M Na-Cacodylate buffer 
5. Post fix in 1% tannic acid in 0.15 M Na-Cacodylate buffer (PH= 7.4) for 1 hour 
a. Adequate volume of tannic acid must be paper filtered before use 
6. Wash 3 x 2 minutes in 0.1M Na-Cacodylate buffer 
7. Post fix in 1 % OsO4 in 0.1M Na Cacodylate buffer for 1 hour 
b. Done in pathology lab (S35?) 
c. See that the fume hood has boost air-flow switched on 
d. Handle osmium very carefully 
e. Small skull and crossbones metallic container contains unused osmium, 
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and big skull and crossbones metallic container is for osmium discard 
f. Keep plastic pipette which made contact with fresh osmium in the sink to 
use again for osmium waste aspiration, and discard it after thorough 
rinsing 
8. Wash 3 x 2 minutes in 0.1M Na-Cacodylate buffer 
9. Dehydrate: 
a. 50 % Ethanol 4 times, each 2 mins 
b. 70 % Ethanol 4 times, each 2 mins 
c. 95 % Ethanol 4 times, each 2 mins 
d. 100 % Ethanol 2 times, each 5 mins   
e. 100 % Molecular sieve ethanol 2 times, each 5 mins   
10. Drying in Hexamethyldisilazane 3 mins 
a. After 100% molecular sieve ethanol treatment, leave the molecular sieve 
ethanol in the respective wells 
b. Bring the Hexamethyldisilazane can from the fridge into the fume hood 
c. Remove the Hexamethyldisilazane bottle from its can and remove the 
parafilm around the neck and cap 
d. Transfer 1 ml of Hexamethyldisilazane per well into dry wells 
corresponding with wells with cell-coated cover-slips and immediately 
transfer into a desiccator and close the lid 
e. Wrap parafilm over the neck and cap of Hexamethyldisilazane bottle, 
place the bottle in its can, and take it back into the fridge 
f. Transfer cover-slips from the wells with molecular sieve ethanol to the 
corresponding wells with 1 ml Hexamethyldisilazane and keep for 3 
minutes; all steps done inside the desiccator kept inside the fume hood 
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g. After 3 minutes, transfer the coverslips from the wells with 1 ml 
Hexamethyldisilazane into corresponding dry wells 
h. Aspirate all molecular sieve ethanol and Hexamethyldisilazane from all 
wells and discard into plastic container and let evaporate inside the fume 
hood 
i. Keep the tray with (coverslips in dry wells) without closing the tray lid 
inside the desiccator and move desiccator outside the fume hood onto the 
work table 
11. Place in desiccator overnight 
12. Mount 
a. Marinate “Grooved SEM Type Slug Mounts” in 100% ethanol for 10 
minutes 
b. Always lift slug mounts with dull-tipped forceps  
c. Always handle coverslips and sticky carbon strips with sharp-tipped 
forceps 
d. Air dry slug mounts on absorbent paper on table with the side with 
concentric circles facing upwards 
e. Label plain side of the slug mounts with appropriate name for permanent 
records 
f. Stick a (double sharp sided shaving blade cut) 2-sided sticky carbon strip 
from a roll of the same on the side with the concentric circles 
g. Lift coverslips from the tray in the desiccator to visualize the cell-layered 
side of the coverslip 
h. Paste coverslips on the sticky carbon strip with the cell-layer side facing 
upwards (away from the sticky carbon adhesive strip) 
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i. Press firmly on the middle of the coverslip with the tip of the sharp-tipped 
forceps to ensure proper adhesion to the sticky carbon strip placed on the 
slug mounts 
j. Using a tip of a toothpick coated with carbon-graphite paint (placed in a 
plastic bottle with a tapering nozzle), paint the non-cellular side of the 
coverslips especially at the junction of the slug mount and the coverslip 
circumferentially 
k. Place a rolled 2-sided adhesive tape on the 24-well-plate cover 
l. Stick the plain side of the slug mounts on the rolled adhesive tape so that 
they will face the wells of the 24-well plate when the 24- well plate is 
placed on the 24-well plate cover 
m. Invert 24-well plate over the firmly stuck slug mounts and place the whole 
set-up in the desiccator with the 24-well plate cover at the bottom and the 
24-well plate bottom facing the top 
13. Coat with gold film 
14. LOOK 
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6.5. Processing of rat liver specimens for scanning electron microscopy 
 
Liver Fixative for SEM/ TEM 
 (Paraformaldehyde & Glutaraldehyde EM Fixative) 
 
1. Composition: 
a. 25 % EM Grade Glutaraldehyde 12 ml 
b. Paraformaldehyde   2 g 
c. 1 M CaCl2    2 ml 
d. Sucrose    2 g 
e. 0.2 M Na Cacodylate Buffer 50 ml 
f. Distilled water   10 ml (or enough to make up to 100 ml 
totally) 
g. Strong NaOH and HCl for pH adjustment  
h. Total Osmolality: 440 milliosmoles 
2. Final Concentrations of Constituents: 
a. 25 % EM Grade Glutaraldehyde 3 % 
b. Paraformaldehyde   2-2.5 % 
c. 1 M CaCl2    2 mmol/ liter 
d. Sucrose    2 % 
e. 0.2 M Na Cacodylate Buffer 0.1 mol/ liter 
f. Distilled water   100 ml 
g. Strong NaOH and HCl for pH adjustment  
3. Preparation Method: 
a. Always prepare fresh (within 24 hours of use) 
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b. Mixture 1 (Glutaraldehyde, Na- Cacodylate, Sucrose) 
i. Add 12 ml Glutaraldehyde, 50 ml of 0.2 M Na Cacodylate buffer, 
and 2 g of sucrose  
c. Mixture 1 (8-10 % Paraformaldehyde)  
i. Weigh out paraformaldehyde wearing gloves in a fume hood and 
avoid inhalation of powder 
ii. Add 2 g of Paraformaldehyde powder to 25 ml of distilled water in 
a beaker 
iii. Heat to 60°C stirring constantly using magnetic stirring bar 
iv. Solution will turn milky 
v. Allow to heat for 2 min 
vi. Cool to 40°C 
vii. Add 1 M NaOH drop-wise, until clear 
viii. Cool to RT 
d. Final mixture (Mixture 1 + Mixture 2) 
i. Add Mixture 1 (Glutaraldehyde, Na- Cacodylate, Sucrose) to 
Mixture 2 (8-10 % Paraformaldehyde, when cool) 
ii. Add 2 ml of 1 M CaCl2 
 
Procedure for Fixing Liver Specimens for SEM/ TEM 
 
1. Perfuse liver with pre-perfusion buffer (Normal Saline) using insulin syringe 
under low pressure: 2 Min 
2. Perfuse liver (In Fume Hood) with Paraformaldehyde & Glutaraldehyde EM 
Fixative using insulin syringe under low pressure UNTIL liver is hard: 
APPROXIMATELY 5 Min 
 207 
3. Cut liver into an appropriate number of 1 mm3 bits 
4. Post-fix in Paraformaldehyde & Glutaraldehyde EM Fixative: 4-24 hours 
(overnight) 
5. Rinse 3 times with 0.1 M Na-Cacodylate, holding liver bits with forceps 
6. Store in 0.1 M Na-Cacodylate till used 
7. Transfer liver bits into appropriately labeled plastic mesh rack layers (WHERE IT 
STAYS FOR THE REST OF THE STEPS) in the specimen holder and place it in 
a polypropylene tube (0.1 M Na-Cacodylate) with a tight cap 
8. THE LIVER BITS STAY IN THIS APPARATUS FOR THE REST OF THE 
STEPS 
9. Post fix in 1 % OsO4 (pathology lab) in 0.1M Na Cacodylate buffer for 2 hours 
10. Wash 2 x 5 minutes in 0.1M Na-Cacodylate buffer 
11. Dehydrate: 
a. 50 % Ethanol 2 times, each 5 mins 
b. 70 % Ethanol 2 times, each 5 mins 
c. 95 % Ethanol 3 times, each 5 mins 
d. 100 % Ethanol 2 times, each 10 mins   
e. 100 % Molecular sieve ethanol 2 times, each 10 mins   
12. Dry with Hexamethyldisilazane in desiccator for 10 mins 
13. Place frame in desiccator overnight 
14. Mount 
a. Marinate “Grooved SEM Type Slug Mounts” in 100% ethanol for 10 
minutes 
b. Always lift slug mounts with dull-tipped forceps  
c. Always handle coverslips and sticky carbon strips with sharp-tipped 
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forceps 
d. Air dry slug mounts on absorbent paper on table with the side with 
concentric circles facing upwards 
e. Label plain side of the slug mounts with appropriate name for permanent 
records 
f. Stick a (double sharp sided shaving blade cut) 2-sided sticky carbon strip 
from a roll of the same on the side with the concentric circles 
g. Place 6 small liver bits (with the even surface facing upwards) on the 
sticky carbon strip of each slog mount 
h. Using a tip of a toothpick coated with carbon-graphite paint, paint bands 
extending from each live bit to the edge of the circular surface of the slug 
mount 
i. Place a rolled 2-sided adhesive tape on a 24-well-plate cover 
j. Stick the plain side of the slug mounts on the rolled adhesive tape so that 
they will face the wells of the 24-well plate when the 24- well plate is 
placed on the 24-well plate cover 
k. Invert 24-well plate over the firmly stuck slug mounts and place the whole 
set-up in the desiccator with the 24-well plate cover at the bottom and the 
24-well plate bottom facing the top 
15. Coat with gold film 
16. Look with SEM: SEM fields should preferably include at least 10 fields/ rat 
encompassing: 
a. At least 2 representative fields/ liver block 
b. At least 5 liver blocks/ rat 
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6.6. Preparation of 4% phosphate buffered paraformaldehyde 
(paraformaldehyde buffered saline) for immunohistochemistry 
 
4% Phosphate-buffered Paraformaldehyde 
 
1. Composition: 
i.Paraformaldehyde 8g 
ii.Distilled water 200 ml 
iii.NaH2PO4.2H2O 0.41 g 
iv.Na2HPO4  2.47 g 
v.NaCl   1 g 
vi.1 N NaOH  “Small Amount” 
2. Preparation: 
i.Weigh out paraformaldehyde wearing gloves in a fume hood and avoid 
inhalation of powder 
ii.In fume cupboard, combine paraformaldehyde and distilled water and 
heat to 60°C 
iii.Add a few drops of 1 N NaOH until solution clears 
iv.Cool the mixture 
v.Add the 3 remaining ingredients and stir until dissolved 
vi.Filter and check pH 
3. Fixation time: 
i.Fixation time prior to immunohistochemistry should be for the shortest 
possible time to achieve good morphology but prevent antigen 
masking due to excessive cross-linking of proteins 
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ii.For blocks of tissue 2 cm square by 3-4 mm thick, 6-24 hours fixation 
is recommended 
iii.For smaller blocks, adequate fixation will be achieved in several hours 
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6.7. Criteria for assessment of pictures obtained for immunohistochemistry for 
pimonidazole and VEGF  
 
Pimonidazole and VEGF IHC Rating Criteria 
 
Rat ID: _______       
        
 PERICENTRAL 
STAINING 
PERIPORTAL 
STAINING 
OVERALL 
STAINING 
Photo 
No: 
PC No. 
Counted 
CP 
Stain 
Nu 
Stain 
PP No. 
Counted 
CP 
Stain 
Nu 
Stain 
PC PP Z2 
 
 
Sinusoid 
Stain? 
 
Bile 
Ductule 
Stain? 
 
“PT” 
Bundles 
1             
2             
3             
4             
5             
6             
7             
8             
9             
10             
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6.8. Criteria for assessment of pictures obtained for immunohistochemistry for 
VEGFR2 
 
VEGFR2 IHC Intensity (0,1,2,3) Rating Criteria 
 
Rat ID: _______       
        
PORTAL AREA INTENSITY 
Z2 AREA 
INTENSITY CENTRAL AREA INTENSITY 
PH
O
TO
 
N
O
.
 
PT 
No 
PT 
Endo 
PP 
Sinusd 
Endo 
(Z-1) 
PP 
Stain
Cm 
PP 
Stain 
Nu 
Z-2 
Sinusd 
Endo 
(Z-2) 
Z-2 
Stain 
Cm 
Z-2 
Stain 
Nu 
CV 
No 
CV 
End 
PC 
Sinusd 
Endo 
(Z-3) 
PC 
Stain 
Cm 
PC 
Stain 
Nu 
O
v
er
al
l 
K
Cs
 
St
el
la
te
 
C 
B
il 
Ep
 
St
 
1                  
2                  
3                  
4                  
5                  
6                  
7                  
 
 
 
